Caroline Chung, MD, MSc., FRCPC, CIP

Peer-Reviewed Articles

1. Gule-Monroe M, Chasen N, Long JP, Kumar VA, Shah K, Chen M, Stafford J, Chung C, Wintermark M, Hou P, Sura E, Wang C, Weinberg J, Liu HL. Diagnostic Confidence of Contrast-Enhanced T1-Weighted MRI for the Detection of Brain Metastases: 3D FSE-vs. 3D GRE-Based Sequences. AJNR Am J Neuroradiol None(None):None, 2024. PMID: 39572196.
2. Yadav D, Upadhyay R, Kumar VA, Chen MM, Johnson JM, Langshaw H, Curl BJ, Farhat M, Talpur W, Beckham TH, Yeboa DN, Swanson TA, Ghia AJ, Li J, Chung C. Additive Value of Magnetic Resonance Simulation Before Chemoradiation in Evaluating Treatment Response and Pseudoprogression in High-Grade Gliomas. Pract Radiat Oncol 14(6):e449-e457, 2024. e-Pub 2024. PMID: 38685448.
3. Leary OP, Zepecki JP, Pizzagalli M, Toms SA, Liu DD, Suita Y, Ding Y, Wang J, He R, Chung C, Fuller CD, Boxerman JL, Tapinos N, Gilbert RJ. Tumor-Associated Tractography Derived from High-Angular-Resolution Q-Space MRI May Predict Patterns of Cellular Invasion in Glioblastoma. Cancers (Basel) 16(21):None, 2024. PMID: 39518107.
4. Butner JD, Dogra P, Chung C, Koay EJ, Welsh JW, Hong DS, Cristini V, Wang Z. Hybridizing mechanistic modeling and deep learning for personalized survival prediction after immune checkpoint inhibitor immunotherapy. NPJ Syst Biol Appl 10(1):88, 2024. e-Pub 2024. PMID: 39143136.
5. Dogra P, Shinglot V, Ruiz-Ramirez J, Cave J, Butner JD, Schiavone C, Duda DG, Kaseb AO, Chung C, Koay EJ, Cristini V, Ozpolat B, Calin GA, Wang Z. Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer. Mol Cancer 23(1):156, 2024. e-Pub 2024. PMID: 39095771.
6. Gibbons C, Baas C, Chung C. Emergence of Digital Toxicity and the Need for an Integrated, Patient-Centric Approach to the Development, Evaluation, and Use of Digital Health Tools for Oncology. JCO Clin Cancer Inform 8(None):e2300105, 2024. PMID: 39106419.
7. Muthusivarajan R, Celaya A, Yung JP, Long JP, Viswanath SE, Marcus DS, Chung C, Fuentes D. Evaluating the relationship between magnetic resonance image quality metrics and deep learning-based segmentation accuracy of brain tumors. Med Phys 51(7):4898-4906, 2024. e-Pub 2024. PMID: 38640464.
8. Wang, C, Rooney, MK, Alvarez-Breckenridge, C, Beckham, TH, Chung, C, De, BS, Ghia, AJ, Grosshans, DR, Majd, NK, McAleer, MF, McGovern, SL, North, RY, Paulino, AC, Perni, S, Reddy, JP, Rhines, LD, Swanson, T, Tatsui, CE, Tom, MC, Yeboa, DN, Li, J. Outcomes and Pattern of Care for Spinal Myxopapillary Ependymoma in the Modern Era—A Population-Based Observational Study. Cancers 16(11), 2024. PMID: 38893133.
9. Beckham TH, Rooney MK, McAleer MF, Ghia AJ, Tom MC, Perni S, McGovern S, Grosshans D, Chung C, Wang C, De B, Swanson T, Paulino A, Jiang W, Ferguson S, Patel CB, Li J, Yeboa DN. Hypofractionated radiotherapy for glioblastoma: A large institutional retrospective assessment of 2 approaches. Neurooncol Pract 11(3):266-274, 2024. e-Pub 2024. PMID: 38737610.
10. Ene CI, Abi Faraj C, Beckham TH, Weinberg JS, Andersen CR, Haider AS, Rao G, Ferguson SD, Alvarez-Brenkenridge CA, Kim BYS, Heimberger AB, McCutcheon IE, Prabhu SS, Wang CM, Ghia AJ, McGovern SL, Chung C, McAleer MF, Tom MC, Perni S, Swanson TA, Yeboa DN, Briere TM, Huse JT, Fuller GN, Lang FF, Li J, Suki D, Sawaya RE. Response of treatment-naive brain metastases to stereotactic radiosurgery. Nat Commun 15(1):3728, 2024. e-Pub 2024. PMID: 38697991.
11. Wang C, Rooney MK, Alvarez-Breckenridge C, Beckham TH, Chung C, De BS, Ghia AJ, Grosshans D, Majd NK, McAleer MF, McGovern SL, North RY, Paulino AC, Perni S, Reddy JP, Rhines LD, Swanson TA, Tatsui CE, Tom MC, Yeboa DN, Li J. Outcomes and Pattern of Care for Spinal Myxopapillary Ependymoma in the Modern Era-A Population-Based Observational Study. Cancers (Basel) 16(11), 2024. e-Pub 2024. PMID: 38893133.
12. Sujit SJ, Aminu M, Karpinets TV, Chen P, Saad MB, Salehjahromi M, Boom JD, Qayati M, George JM, Allen H, Antonoff MB, Hong L, Hu X, Heeke S, Tran HT, Le X, Elamin YY, Altan M, Vokes NI, Sheshadri A, Lin J, Zhang J, Lu Y, Behrens C, Godoy MCB, Wu CC, Chang JY, Chung C, Jaffray DA, Wistuba II, Lee JJ, Vaporciyan AA, Gibbons DL, Heymach J, Zhang J, Cascone T, Wu J. Enhancing NSCLC recurrence prediction with PET/CT habitat imaging, ctDNA, and integrative radiogenomics-blood insights. Nat Commun 15(1):3152, 2024. e-Pub 2024. PMID: 38605064.
13. Butner JD, Dogra P, Chung C, Koay EJ, Welsh JW, Hong DS, Cristini V, Wang Z. Hybridizing mechanistic mathematical modeling with deep learning methods to predict individual cancer patient survival after immune checkpoint inhibitor therapy. Res Sq, 2024. e-Pub 2024. PMID: 38586046.
14. Salehjahromi M, Karpinets TV, Sujit SJ, Qayati M, Chen P, Aminu M, Saad MB, Bandyopadhyay R, Hong L, Sheshadri A, Lin J, Antonoff MB, Sepesi B, Ostrin EJ, Toumazis I, Huang P, Cheng C, Cascone T, Vokes NI, Behrens C, Siewerdsen JH, Hazle JD, Chang JY, Zhang J, Lu Y, Godoy MCB, Chung C, Jaffray D, Wistuba I, Lee JJ, Vaporciyan AA, Gibbons DL, Gladish G, Heymach JV, Wu CC, Zhang J, Wu J. Synthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of concept. Cell Rep Med 5(3):101463, 2024. e-Pub 2024. PMID: 38471502.
15. Elliott A, Villemoes E, Farhat M, Klingberg E, Langshaw H, Svensson S, Chung C. Development and benchmarking diffusion magnetic resonance imaging analysis for integration into radiation treatment planning. Med Phys 51(3):2108-2118, 2024. e-Pub 2023. PMID: 37633837.
16. Qin K, Wang K, Li S, Hong L, Padmakumar P, Waree R, Hubert SM, Le X, Vokes N, Rai K, Vaporciyan A, Gibbons DL, Heymach JV, Lee JJ, Woodman SE, Chung C, Jaffray DA, Altan M, Lou Y, Zhang J. Clinical Benefit from Docetaxel +/- Ramucirumab Is Not Associated with Mutation Status in Metastatic Non-Small-Cell Lung Cancer Patients Who Progressed on Platinum Doublets and Immunotherapy. Cancers (Basel) 16(5), 2024. e-Pub 2024. PMID: 38473297.
17. Hoebel KV, Bridge CP, Ahmed S, Akintola O, Chung C, Huang RY, Johnson JM, Kim A, Ly KI, Chang K, Patel J, Pinho M, Batchelor TT, Rosen BR, Gerstner ER, Kalpathy-Cramer J. Expert-centered Evaluation of Deep Learning Algorithms for Brain Tumor Segmentation. Radiol Artif Intell 6(1):e220231, 2024. PMID: 38197800.
18. Karschnia P, Smits M, Reifenberger G, Le Rhun E, Ellingson BM, Galldiks N, Kim MM, Huse JT, Schnell O, Harter PN, Mohme M, von Baumgarten L, Albert NL, Huang RY, Mehta MP, van den Bent M, Weller M, Vogelbaum MA, Chang SM, Berger MS, Tonn JC. A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups. Lancet Oncology 24(11):438-450, 2023. PMID: 37922934.
19. Noh S, Bertini C, Mira-Avendano I, Kaous M, Patel B, Faiz SA, Shannon VR, Balachandran DD, Bashoura L, Adachi R, Evans SE, Dickey B, Wu C, Shroff GS, Manzano JG, Granwehr B, Holloway S, Dickson K, Mohammed A, Muthu M, Song H, Team D, Chung C, Wu J, Lee L, Jiang Y, Khawaja F, Sheshadri A. Interstitial lung abnormalities after hospitalization for COVID-19 in patients with cancer: A prospective cohort study. Cancer Med 12(17):17753-17765, 2023. e-Pub 2023. PMID: 37592894.
20. Farhat M, Fuller GN, Wintermark M, Chung C, Kumar VA, Chen M. Multifocal and multicentric glioblastoma: Imaging signature, molecular characterization, patterns of spread, and treatment. Neuroradiol J:19714009231193162. e-Pub 2023. PMID: 37559514.
21. Saad MB, Hong L, Aminu M, Vokes NI, Chen P, Salehjahromi M, Qin K, Sujit SJ, Lu X, Young E, Al-Tashi Q, Qureshi R, Wu CC, Carter BW, Lin SH, Lee PP, Gandhi S, Chang JY, Li R, Gensheimer MF, Wakelee HA, Neal JW, Lee HS, Cheng C, Velcheti V, Lou Y, Petranovic M, Rinsurongkawong W, Le X, Rinsurongkawong V, Spelman A, Elamin YY, Negrao MV, Skoulidis F, Gay CM, Cascone T, Antonoff MB, Sepesi B, Lewis J, Wistuba II, Hazle JD, Chung C, Jaffray D, Gibbons DL, Vaporciyan A, Lee JJ, Heymach JV, Zhang J, Wu J. Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study. Lancet Digit Health 5(7):e404-e420, 2023. e-Pub 2023. PMID: 37268451.
22. Altan M, Wang Y, Song J, Welsh J, Tang C, Guha-Thakurta N, Blumenschein GR, Carter BW, Wefel JS, Ghia AJ, Yeboa DN, McAleer MF, Chung C, Woodhouse KD, McGovern SL, Wang C, Kim BYS, Weinberg JS, Briere TM, Elamin YY, Le X, Cascone T, Negrao MV, Skoulidis F, Ferrarotto R, Heymach JV, Li J. Nivolumab and ipilimumab with concurrent stereotactic radiosurgery for intracranial metastases from non-small cell lung cancer: analysis of the safety cohort for non-randomized, open-label, phase I/II trial. J Immunother Cancer 11(7), 2023. PMID: 37402581.
23. Hasanov M, Milton DR, Davies AB, Sirmans E, Saberian C, Posada EL, Opusunju S, Gershenwald JE, Torres-Cabala CA, Burton EM, Colen RR, Huse JT, Glitza Oliva IC, Chung C, McAleer MF, McGovern SL, Yeboa DN, Kim BYS, Prabhu SS, McCutcheon IE, Weinberg JS, Lang FF, Tawbi HA, Li J, Haydu LE, Davies MA, Ferguson SD. Changes In Outcomes And Factors Associated With Survival In Melanoma Patients With Brain Metastases. Neuro Oncol 25(7):1310-1320, 2023. e-Pub 2022. PMID: 36510640.
24. Chakrabarty S, Abidi SA, Mousa M, Mokkarala M, Hren I, Yadav D, Kelsey M, LaMontagne P, Wood J, Adams M, Su Y, Thorpe S, Chung C, Sotiras A, Marcus DS. Integrative Imaging Informatics for Cancer Research: Workflow Automation for Neuro-Oncology (I3CR-WANO). JCO Clin Cancer Inform 7, 2023. PMID: 37146265.
25. Celaya, A, Actor, JA, Muthusivarajan, R, Gates, ED, Chung, C, Schellingerhout, D, Rivière, B, Fuentes, DA. PocketNet. IEEE Transactions on Medical Imaging 42(4):1172-1184, 2023. PMID: 36427285.
26. Celaya A, Actor JA, Muthusivarajan R, Gates E, Chung C, Schellingerhout D, Riviere B, Fuentes AD. PocketNet: A Smaller Neural Network for Medical Image Analysis. IEEE 42(4):1172-1184, 2023. PMID: None.
27. Reddy, DS, Cuenca, JA, Botdorf, JS, Muthu, M, Hanmandlu, A, Wegner, RC, Crommett, JW, Gutierrez, C, Rathi, N, Sajith, B, Knafl, M, Abbas, HA, Woodman, SE, Nates, JL, Aaroe, AE, Aloia, TA, Andrews, L, Badami, KK, Baganz, JA, Bajwa, P, Baker, LR, Barbosa, GR, Beird, H, Bourgeois, M, Brock, K, Burton, EM, Cata, JP, Chung, C, Cutherell, M, Dabaja, BS, Draetta, G, French, KE, Futreal, A, Gibbons, C, Godoy, M, Gunther, J, Hutcheson, KA, Jaffray, D, John, TM, Lee, JJ, Litton, J, McEnery, KW, Palaskas, NL, Ravi, V, Scheet, PA, Schmidt, S, Subbiah, IM, Tawbi, H, Wu, J, Yao, JC. Clinical Characteristics and Cause of Death Among Hospitalized Decedents With Cancer and COVID-19. Mayo Clinic Proceedings 98(3):451-457, 2023. PMID: 36868753.
28. Xiao Y, Cardenas C, Rhee DJ, Netherton T, Zhang L, Nguyen C, Douglas R, Mumme R, Skett S, Patel T, Trauernicht C, Chung C, Simonds H, Aggarwal A, Court L. Customizable landmark-based field aperture design for automated whole-brain radiotherapy treatment planning. J Appl Clin Med Phys 24(3):e13839, 2023. e-Pub 2022. PMID: 36412092.
29. Li, W, Bootsma, G, Shultz, DB, Laperriere, N, Millar, BA, Cho, YB, Jaffray, D, Chung, C, Coolens, C. Assessment of intra-fraction motion during frameless image guided Gamma Knife stereotactic radiosurgery. Physics and Imaging in Radiation Oncology 25, 2023. PMID: 36718356.
30. Cata JP, Hu J, Feng L, Chung C, Woodman SE, Meyer LA. Association between COVID-19 and Postoperative Neurological Complications and Antipsychotic Medication Use after Cancer Surgery: A Retrospective Study. J Pers Med 13(2), 2023. PMID: 36836508.
31. McGovern SL, Luo D, Johnson J, Nguyen K, Li J, McAleer MF, Yeboa D, Grosshans DR, Ghia AJ, Chung C, Bishop AJ, Song J, Thall PF, Brown PD, Mahajan A. A Prospective Study of Conventionally Fractionated Dose Constraints for Re-Irradiation of Primary Brain Tumors in Adults. Pract Radiat Oncol 13(3):231-238, 2023. e-Pub 2022. PMID: 36596356.
32. Buszek SM, Tran B, Long JP, Luo D, Suki D, Li J, Ferguson S, Chung C. Postoperative Management of Recurrence after Radiosurgery and Surgical Resection for Brain Metastases and Predicting Benefit from Adjuvant Radiation. Pract Radiat Oncol 13(6):e499-e503, 2023. e-Pub 2023. PMID: 37295724.
33. Aminu M, Daver N, Godoy MCB, Shroff G, Wu C, Torre-Sada LF, Goizueta A, Shannon VR, Faiz SA, Altan M, Garcia-Manero G, Kantarjian H, Ravandi-Kashani F, Kadia T, Konopleva M, DiNardo C, Pierce S, Naing A, Kim ST, Kontoyiannis DP, Khawaja F, Chung C, Wu J, Sheshadri A. Heterogenous lung inflammation CT patterns distinguish pneumonia and immune checkpoint inhibitor pneumonitis and complement blood biomarkers in acute myeloid leukemia: proof of concept. Front Immunol 14:1249511, 2023. e-Pub 2023. PMID: 37841255.
34. Aminu M, Yadav D, Hong L, Young E, Edelkamp P, Saad M, Salehjahromi M, Chen P, Sujit SJ, Chen MM, Sabloff B, Gladish G, de Groot PM, Godoy MCB, Cascone T, Vokes NI, Zhang J, Brock KK, Daver N, Woodman SE, Tawbi HA, Sheshadri A, Lee JJ, Jaffray D, Team D, Wu CC, Chung C, Wu J. Habitat Imaging Biomarkers for Diagnosis and Prognosis in Cancer Patients Infected with COVID-19. Cancers (Basel) 15(1), 2022. e-Pub 2022. PMID: 36612278.
35. Aminu M, Yadav D, Hong L, Young E, Edelkamp P, Jr, Saad M, Salehjahromi M, Chen P, Sujit SJ, Chen MM, Sabloff B, Gladish G, de Groot PM, B Godoy MC, Cascone T, Vokes NI, Zhang J, Brock KK, Daver N, Woodman SE, Tawbi HA, Sheshadri A, Lee J, Jaffray D, Team D, Wu CC, Chung C, Wu AJ. Habitat Imaging Biomarkers for Diagnosis and Prognosis in Cancer Patients Infected with COVID‐19. Cancers 15(275), 2022. PMID: None.
36. Butner JD, Farhat M, Cristini V, Chung C, Wang Z. Protocol for mathematical prediction of patient response and survival to immune checkpoint inhibitor immunotherapy. STAR Protoc 3(4):101886, 2022. e-Pub 2022. PMID: 36595890.
37. Tsang, D, Khandwala, MM, Liu, ZA, Richard, NM, Shen, G, Sekely, A, Bernstein, LJ, Simpson, R, Mason, W, Chung, C, De Moraes, FY, Murray, L, Shultz, DB, Laperriere, N, Millar, BA, Edelstein, K. Neurocognitive Performance in Adults Treated With Radiation for a Primary Brain Tumor. Advances in Radiation Oncology 7(6), 2022. PMID: 36420185.
38. Bronk JK, Amer A, Khose S, Flint D, Adair A, Yepes P, Grosshans D, Johnson J, Chung C. Brain Radiation Necrosis Outside the Target Volume After Proton Radiation Therapy: Analyses of Multiparametric Imaging and Proton Biologic Effectiveness. Adv Radiat Oncol 7(6), 2022. PMID: 36420203.
39. Netherton TJ, Nguyen C, Cardenas CE, Chung C, Klopp AH, Colbert LE, Rhee DJ, Peterson CB, Howell R, Balter P, Court LE. An Automated Treatment Planning Framework for Spinal Radiation Therapy and Vertebral-Level Second Check. Int J Radiat Oncol Biol Phys 114(3):516-528, 2022. e-Pub 2022. PMID: 35787928.
40. Farhat, Maguy, Hormuth, David, Langshaw, Holly, Bronk, Juliana, Curl, Brandon, Yadav, Divya, Upadhyay, Rituraj, Elliot, Andrew, Goldman, Jodi, Erickson, Lily, Talpur, Wasif, Lee, Maggie, Yankeelov, Thomas, Chung, Caroline. NIMG-79. SPATIALLY MAPPED PREDICTIONS OF EVOLVING TUMOR RESPONSE OF HIGH-GRADE GLIOMA VIA IMAGE-DRIVEN MATHEMATICAL MODELING. Neuro-Oncology, 2022. PMID: None.
41. Celaya A, Actor JA, Muthusivarajan R, Gates E, Chung C, Schellingerhout D, Riviere B, Fuentes AD. PocketNet: A Smaller Neural Network For Medical Image Analysis. IEEE TRANSACTIONS ON MEDICAL IMAGING, 2022. PMID: None.
42. Mitchell, Drew, Buszek, Samantha, Tran, Benjamin, Farhat, Maguy, Goldman, Jodi, Erickson, Lily, Curl, Brandon, Suki, Dima, Ferguson, Sherise, Liu, Ho-Ling, Kundu, Suprateek, Chung, Caroline. Managing the effect of magnetic resonance imaging pulse sequence on radiomic feature reproducibility in the study of brain metastases. F1000 Research, 2022. PMID: None.
43. Ellingson BM, Gerstner ER, Lassman AB, Chung C, Colman H, Cole PE, Leung D, Allen JE, Ahluwalia MS, Boxerman J, Brown M, Goldin J, Nduom E, Hassan I, Gilbert MR, Mellinghoff IK, Weller M, Chang S, Arons D, Meehan C, Selig W, Tanner K, Alfred Yung WK, van den Bent M, Wen PY, Cloughesy TF. Hypothetical Generalized Framework for a New Imaging Endpoint of Therapeutic Activity in Early Phase Clinical Trials in Brain Tumors. Neuro Oncol 24(8):1219-1229, 2022. e-Pub 2022. PMID: 35380705.
44. Tran, Benjamin, Buszek, Samantha, Mitchell, Drew, Long, James, Elliott, Andrew, Langshaw, Holly, Erickson, Lily, Farhat, Maguy, Bronk, Julianna, Ferguson, Sherise, Chung, Caroline. NEIM-06 COMBINING CLINICAL VARIABLES AND RADIOMIC FEATURES TO HELP DISTINGUISH RADIATION NECROSIS FROM TUMOR IN PATIENTS WITH MELANOMA BRAIN METASTASES TREATED WITH RADIOSURGERY. Neuro-Oncology Advances, 2022. PMID: None.
45. Bronk, Julianna, Muir, Matthew, Michener, Hayley, Calbat, Courtney, Mackin, Dennis, Mitchell, Drew, Train, Benjamin, Farhat, Maguy, Elliot, Andrew, Prabhu, Sujit, Prinsloo, Sarah, Chung, Caroline. NEIM-05 FEASIBILITY OF NAVIGATED TRANSCRANIAL MAGNETIC STIMULATION (NTMS) BASED DIFFUSION TENSOR IMAGING (DTI) TRACTOGRAPHY OF MOTOR PATHWAYS IN PATIENTS UNDERGOING STEREOTACTIC RADIOSURGERY: A CROSS-SECTIONAL DOSIMETRIC AND PATIENT OUTCOMES ANALYSIS. Neuro-Oncology Advances, 2022. PMID: None.
46. Tsang, Derek, Khandwala, Mohammad, Liu, Zhihui, Richard, Nadine, Shen, Gerald, Sekely, Angela, Bernstein, Lori, Simpson, Rebecca, Mason, Warren, Chung, Caroline, Moraes, Fabio, Murray, Louise, Shultz, David, Laperriere, Normand, Millar, Barbara-Ann, Edelstein, Kim. Neurocognitive Performance in Adults Treated With Radiation for a Primary Brain Tumor. Advances in Radiation Oncology 7(6), 2022. PMID: None.
47. Netherton, Tucker, Nguyen, Callistus, Cardenas, Carlos, Chung, Caroline, Klopp, Ann, Colbert, Lauren, Rhee, Dong, Peterson, Christine, HowellPhD, Rebecca, Balter, Peter, Court, Laurence. An automated treatment planning framework for spinal radiotherapy and vertebral level second check. International Journal of Radiation Oncology*Biology*Physics, 2022. PMID: None.
48. Subbiah, Ishwaria, Daftary, Utpala, Peek, Angela, Christensen, Sarah, Small, Fernando, Vincitore, Brandon, Ali, Sara, Subbiah, Vivek, Roszik, Jason, Mendoza, Tito, Sidey-Gibbons, Chris, Chung, Caroline, Williams, Loretta. Association between telehealth and adherence with patient-reported outcomes (PRO)-based remote symptom monitoring among adolescent/young adults (AYA), middle age, and older adults with cancer. Journal of Clinical Oncology 40, 2022. PMID: None.
49. Chung C, Brown PD, Wefel JS. Lessons learned from proton vs photon radiation therapy for glioblastoma signal-finding trial. Neuro Oncol 24(5):851, 2022. e-Pub 2022. PMID: 35460425.
50. Butner JD, Dogra P, Chung C, Ruiz-Ramírez J, Nizzero S, Plodinec M, Li X, Pan PY, Chen SH, Cristini V, Ozpolat B, Calin GA, Wang Z. Dedifferentiation-mediated stem cell niche maintenance in early-stage ductal carcinoma in situ progression: insights from a multiscale modeling study. Cell Death Dis 13(5):485, 2022. e-Pub 2022. PMID: 35597788.
51. Buchsbaum JC, Jaffray DA, Ba D, Borkon LL, Chalk C, Chung C, Coleman MA, Coleman CN, Diehn M, Droegemeier KK, Enderling H, Espey MG, Greenspan EJ, Hartshorn CM, Hoang T, Hsiao HT, Keppel C, Moore NW, Prior F, Stahlberg EA, Tourassi G, Willcox KE. Predictive Radiation Oncology - A New NCI-DOE Scientific Space and Community. Radiat Res 197(4):434-445, 2022. e-Pub 2022. PMID: 35090025.
52. Dogra P, Ramírez JR, Butner JD, Peláez MJ, Chung C, Hooda-Nehra A, Pasqualini R, Arap W, Cristini V, Calin GA, Ozpolat B, Wang Z. Translational Modeling Identifies Synergy between Nanoparticle-Delivered miRNA-22 and Standard-of-Care Drugs in Triple-Negative Breast Cancer. Pharm Res 39(3):511-528, 2022. e-Pub 2022. PMID: 35294699.
53. Uppal A, Kothari AN, Scally CP, Roland CL, Bednarski BK, Katz MHG, Vauthey JN, Chang GJ, Team D. Adoption of Telemedicine for Postoperative Follow-Up After Inpatient Cancer-Related Surgery. JCO Oncol Pract:OP2100819. e-Pub 2022. PMID: 35263166.
54. Lee KP, Koshelev MV, Team D, Pacha O. The effect of biologic therapy for immune-mediated inflammatory diseases on clinical outcomes of COVID-19 in the greater Houston area: A retrospective chart review. J Am Acad Dermatol. e-Pub 2022. PMID: 35016993.
55. Buchsbaum, Jeffrey, Jaffray, David, Ba, Demba, Borkon, Lynn, Chalk, Christine, Chung, Caroline, Coleman, Matthew, Coleman, C, Diehn, Maximilian, Droegemeier, Kelvin, Enderling, Heiko, Espey, Michael, Greenspan, Emily, Hartshorn, Christopher, Hoang, Thuc, Hsiao, H, Keppel, Cynthia, Moore, Nathan, Prior, Fred, Willcox, Karen. Predictive Radiation Oncology – A New NCI–DOE Scientific Space and Community. Radiation Research, 2022. PMID: None.
56. Goldman J, Hagiwara A, Yao J, Raymond C, Ong C, Bakhti R, Kwon E, Farhat M, Torres C, Erickson LG, Curl BJ, Lee M, Pope WB, Salamon N, Nghiemphu PL, Ji M, Eldred BS, Liau LM, Lai A, Cloughesy TF, Chung C, Ellingson BM. Paradoxical Association Between Relative Cerebral Blood Volume Dynamics Following Chemoradiation and Increased Progression-Free Survival in Newly Diagnosed IDH Wild-Type MGMT Promoter Methylated Glioblastoma With Measurable Disease. Front Oncol 12:849993, 2022. e-Pub 2022. PMID: 35371980.
57. Kim Y, Zhu L, Zhu H, Li X, Huang Y, Gu C, Bush H, Chung C, Zhang GQ. Characterizing cancer and COVID-19 outcomes using electronic health records. PLoS One 17(5):e0267584, 2022. e-Pub 2022. PMID: 35507598.
58. Tawbi HA, Forsyth PA, Hodi FS, Algazi AP, Hamid O, Lao CD, Moschos SJ, Atkins MB, Lewis K, Postow MA, Thomas RP, Glaspy J, Jang S, Khushalani NI, Pavlick AC, Ernstoff MS, Reardon DA, Kudchadkar R, Tarhini A, Chung C, Ritchings C, Durani P, Askelson M, Puzanov I, Margolin KA. Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study. Lancet Oncol 22(12):1692-1704, 2021. e-Pub 2021. PMID: 34774225.
59. Kothari AN, DiBrito SR, Lee JJ, Caudle AS, Clemens MW, Gottumukkala VN, Katz MHG, Offodile AC, Uppal A, Team D, Chang GJ. Surgical Outcomes in Cancer Patients Undergoing Elective Surgery After Recovering from Mild-to-Moderate SARS-CoV-2 Infection. Ann Surg Oncol 28(13):8046-8053, 2021. e-Pub 2021. PMID: 34176060.
60. Chung C, Jaffray DA. Cancer Needs a Robust "Metadata Supply Chain" to Realize the Promise of Artificial Intelligence. Cancer Res 81(23):5810-5812, 2021. PMID: 34853038.
61. Butner JD, Martin GV, Wang Z, Corradetti B, Ferrari M, Esnaola N, Chung C, Hong DS, Welsh JW, Hasegawa N, Mittendorf EA, Curley SA, Chen SH, Pan PY, Libutti SK, Ganesan S, Sidman RL, Pasqualini R, Arap W, Koay EJ, Cristini V. Early prediction of clinical response to checkpoint inhibitor therapy in human solid tumors through mathematical modeling. Elife 10, 2021. e-Pub 2021. PMID: 34749885.
62. Chung C, Brown PD, Wefel JS. Short reply to "Proton therapy for newly diagnosed glioblastoma: More room for investigation" by R. Press et al. Neuro Oncol 23(11):1982, 2021. e-Pub 2021. PMID: 34453547.
63. Kotla S, Zhang A, Imanishi M, Ko KA, Lin SH, Gi YJ, Moczygemba M, Isgandarova S, Schadler KL, Chung C, Milgrom SA, Banchs J, Yusuf SW, Amaya DN, Guo H, Thomas TN, Shen YH, Deswal A, Herrmann J, Kleinerman ES, Entman ML, Cooke JP, Schifitto G, Maggirwar SB, McBeath E, Gupte AA, Krishnan S, Patel ZS, Yoon Y, Burks JK, Fujiwara K, Brookes PS, Le NT, Hamilton DJ, Abe JI. Nucleus-mitochondria positive feedback loop formed by ERK5 S496 phosphorylation-mediated poly (ADP-ribose) polymerase activation provokes persistent pro-inflammatory senescent phenotype and accelerates coronary atherosclerosis after chemo-radiation. Redox Biol 47:102132, 2021. e-Pub 2021. PMID: 34619528.
64. Tawbi, Hussein, Forsyth, PA, Hodi, FS, Algazi, A, Hamid, O, Lao, CD, Moschos, Stergios, Atkins, MB, Lewis, K, Postow, MA, Thomas, RP, Khushalani, NI, Pavlick, Anna, Ernstoff, Marc, Reardon, DA, Chung, Caroline, Lee, C-W, Bas, Tuba, Askelson, Margarita, Margolin, Kim. 1039MO CheckMate 204: 3-year outcomes of treatment with combination nivolumab (NIVO) plus ipilimumab (IPI) for patients (pts) with active melanoma brain metastases (MBM). Annals of Oncology 32:S871-S872, 2021. PMID: None.
65. Chung, Caroline, Brown, Paul, Wefel, Jeffrey. Short reply to “Proton therapy for newly diagnosed glioblastoma: More room for investigation”. Neuro-Oncology 23(8), 2021. PMID: None.
66. Wang J, Salzillo T, Jiang Y, Mackeyev Y, David Fuller C, Chung C, Choi S, Hughes N, Ding Y, Yang J, Vedam S, Krishnan S. Stability of MRI contrast agents in high-energy radiation of a 1.5T MR-Linac. Radiother Oncol 161:55-64, 2021. e-Pub 2021. PMID: 34089753.
67. Brown PD, Chung C, Liu DD, McAvoy S, Grosshans D, Al Feghali K, Mahajan A, Li J, McGovern SL, McAleer MF, Ghia AJ, Sulman EP, Penas-Prado M, de Groot JF, Heimberger AB, Wang J, Armstrong TS, Gilbert MR, Guha-Thakurta N, Wefel JS. A Prospective Phase II Randomized Trial of Proton Radiotherapy vs. Intensity Modulated Radiotherapy for Patients with Newly Diagnosed Glioblastoma. Neuro Oncol 23(8):1337-1347, 2021. e-Pub 2021. PMID: 33647972.
68. Thrower SL, Al Feghali KA, Luo D, Paddick I, Hou P, Briere T, Li J, McAleer MF, McGovern SL, Woodhouse KD, Yeboa DN, Brock KK, Chung C. The Effect of Slice Thickness on Contours of Brain Metastases for Stereotactic Radiosurgery. Adv Radiat Oncol 6(4):100708, 2021. e-Pub 2021. PMID: 34124413.
69. McGee KP, Hwang KP, Sullivan DC, Kurhanewicz J, Hu Y, Wang J, Li W, Debbins J, Paulson E, Olsen JR, Hua CH, Warner L, Ma D, Moros E, Tyagi N, Chung C. Magnetic resonance biomarkers in radiation oncology: The report of AAPM Task Group 294. Med Phys 48(7):e697-e732, 2021. e-Pub 2021. PMID: 33864283.
70. Julián-Serrano S, Yuan F, Wheeler W, Benyamin B, Machiela MJ, Arslan AA, Beane-Freeman LE, Bracci PM, Duell EJ, Du M, Gallinger S, Giles GG, Goodman PJ, Kooperberg C, Marchand LL, Neale RE, Shu XO, Van Den Eeden SK, Visvanathan K, Zheng W, Albanes D, Andreotti G, Ardanaz E, Babic A, Berndt SI, Brais LK, Brennan P, Bueno-de-Mesquita B, Buring JE, Chanock SJ, Childs EJ, Chung C, Fabiánová E, Foretová L, Fuchs CS, Gaziano JM, Gentiluomo M, Giovannucci EL, Goggins MG, Hackert T, Hartge P, Hassan MM, Holcátová I, Holly EA, Hung RI, Janout V, Kurtz RC, Lee IM, Malats N, McKean D, Milne RL, Newton CC, Oberg AL, Perdomo S, Peters U, Porta M, Rothman N, Schulze MB, Sesso HD, Silverman DT, Thompson IM, Wactawski-Wende J, Weiderpass E, Wenstzensen N, White E, Wilkens LR, Yu H, Zeleniuch-Jacquotte A, Zhong J, Kraft P, Li D, Campbell PT, Petersen GM, Wolpin BM, Risch HA, Amundadottir LT, Klein AP, Yu K, Stolzenberg-Solomon RZ. Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies. Am J Clin Nutr. e-Pub 2021. PMID: 34258619.
71. Williams, Loretta, Whisenant, Meagan, Mendoza, Tito, Malveaux, Donna, Griffin, Donna, Ponce, Darcy, Cleeland, Charles, Peek, Angela, Granwehr, Bruno, Hutcheson, Kate, Shaw, Kenna, Md, Vinod, Woodman, Scott, Chung, Caroline, Aloia, Thomas, Futreal, Phillip, Jaffray, David, Subbiah, Ishwaria. Development and validation of a novel patient-reported outcomes (PRO) measure for symptom burden in patients with cancer and COVID-19 infection. Journal of Clinical Oncology, 2021. PMID: None.
72. Hasanov, Merve, Milton, Denai, Davies, Alicia, Sirmans, Elizabeth, Saberian, Chantal, Posada, Eliza, Gershenwald, Jeffrey, Torres-Cabala, Carlos, Huse, Jason, Hassan, Abdul, Glitza, Isabella, Li, Jing, Chung, Caroline, Yeboa, Debra, Opusunju, Sylvia, Kim, Betty, Lang, Frederick, Haydu, Lauren, Davies, Michael, Ferguson, Sherise. Predictors of overall survival (OS) in patients (pts) with melanoma brain metastasis (MBM) in the modern era. Journal of Clinical Oncology 39:9540-9540, 2021. PMID: None.
73. Mamlouk O, Turin A, D'Achiardi D, Simbaqueba C, Dickson K, Franco-Vega M, Halm J, Mandayam S, Team D. Clinical characteristics and outcomes of cancer patients with chronic kidney disease and coronavirus disease 2019. Journal of Clinical Oncology 39(15). e-Pub 2021. PMID: None.
74. Subbiah, Ishwaria, Williams, Loretta, Peek, Angela, Shete, Sanjay, Granwehr, Bruno, D'Achiardi, David, Turin, Anastasia, Garcia, Elizabeth, Finder, Janice, Chemaly, Roy, Beltran, Kimberly, Shaw, Kenna, Whisenant, Meagan, Woodman, Scott, Md, Vinod, Hassan, Abdul, Subbiah, Vivek, Chung, Caroline, Futreal, Phillip, Jaffray, David. Real-world patient-reported and clinical outcomes of BNT162b2 mRNA COVID-19 vaccine in patients with cancer. Journal of Clinical Oncology 39, 2021. PMID: None.
75. Hormuth DA, Al Feghali KA, Elliott AM, Yankeelov TE, Chung C. Image-based personalization of computational models for predicting response of high-grade glioma to chemoradiation. Sci Rep 11(1):8520, 2021. e-Pub 2021. PMID: 33875739.
76. Butner JD, Wang Z, Elganainy D, Al Feghali KA, Plodinec M, Calin GA, Dogra P, Nizzero S, Ruiz-Ramírez J, Martin GV, Tawbi HA, Chung C, Koay EJ, Welsh JW, Hong DS, Cristini V. A mathematical model for the quantification of a patient's sensitivity to checkpoint inhibitors and long-term tumour burden. Nat Biomed Eng 5(4):297-308, 2021. e-Pub 2021. PMID: 33398132.
77. Al Feghali KA, Buszek SM, Elhalawani H, Chevli N, Allen PK, Chung C. Real-world evaluation of the impact of radiotherapy and chemotherapy in elderly patients with glioblastoma based on age and performance status. Neurooncol Pract 8(2):199-208, 2021. e-Pub 2020. PMID: 33898053.
78. Butner, Joe, Wang, Zhihui, Elganainy, Dalia, Al-Feghali, Karine, Plodinec, Marija, Calin, George, Dogra, Prashant, Nizzero, Sara, Ruiz-Ramírez, Javier, Martin, Geoffrey, Tawbi, Hussein, Chung, Caroline, Koay, Eugene, Welsh, James, Hong, David, Cristini, Vittorio. A mathematical model for the quantification of a patient’s sensitivity to checkpoint inhibitors and long-term tumour burden. Nature Biomedical Engineering 5(4), 2021. PMID: None.
79. Mohan R, Liu AY, Brown PD, Mahajan A, Dinh J, Chung C, McAvoy S, McAleer MF, Lin SH, Li J, Ghia AJ, Zhu C, Sulman EP, de Groot JF, Heimberger AB, McGovern SL, Grassberger C, Shih H, Ellsworth S, Grosshans DR. Proton Therapy Reduces the Likelihood of High-Grade Radiation-Induced Lymphopenia in Glioblastoma Patients: Phase II Randomized Study of Protons vs. Photons. Neuro Oncol 23(2):284-294, 2021. e-Pub 2020. PMID: 32750703.
80. Al Feghali KA, Randall JW, Liu DD, Wefel JS, Brown PD, Grosshans DR, McAvoy SA, Farhat MA, Li J, McGovern SL, McAleer MF, Ghia AJ, Paulino AC, Sulman EP, Penas-Prado M, Wang J, de Groot J, Heimberger AB, Armstrong TS, Gilbert MR, Mahajan A, Guha-Thakurta N, Chung C. Phase II trial of proton therapy versus photon IMRT for GBM: secondary analysis comparison of progression-free survival between RANO versus clinical assessment. Neurooncol Adv 3(1):vdab073, 2021. e-Pub 2021. PMID: 34337411.
81. SandstrÖm H, Toma-Dasu I, Chung C, GÅrding J, Jokura H, Dasu A. Simultaneous Truth and Performance Level Estimation Method for Evaluation of Target Contouring in Radiosurgery. Anticancer Res 41(1):279-288, 2021. PMID: 33419822.
82. Omary, Reed, Chung, Caroline, Lee, Christoph. The Provocative: A Glimpse Into Radiology’s Future. Journal of the American College of Radiology: JACR 18(1), 2021. PMID: None.
83. Jhawar SR, Palmer JD, Wang SJ, Bitterman D, Klamer B, Huynh-Le M, Chung C, Ohri N, Stover DG, Lustberg MB, Mishra S, Warner J, Jabbour S, Goyal S, Group CCC. The COVID-19 & Cancer Consortium (CCC19) and Opportunities for Radiation Oncology. Adv Radiat Oncol 6(1):100614, 2021. e-Pub 2020. PMID: 33521393.
84. Hormuth DA, Jarrett AM, Lorenzo G, EABF L, Wu C, Chung C, Patt D, Yankeelov TE. Math, magnets, and medicine: enabling personalized oncology. Expert Rev Precis Med Drug Dev 6(2):79-81, 2021. e-Pub 2021. PMID: 34027102.
85. Kaufmann TJ, Smits M, Boxerman J, Huang R, Barboriak DP, Weller M, Chung C, Tsien C, Brown PD, Shankar L, Galanis E, Gerstner E, van den Bent MJ, Burns TC, Parney IF, Dunn G, Brastianos PK, Lin NU, Wen PY, Ellingson BM. Response to Letter to Editor. Neuro Oncol 22(11):1706-1707, 2020. PMID: 32823280.
86. Netherton TJ, Rhee DJ, Cardenas CE, Chung C, Klopp AH, Peterson CB, Howell RM, Balter PA, Court LE. Evaluation of a multiview architecture for automatic vertebral labeling of palliative radiotherapy simulation CT images. Med Phys 47(11):5592-5608, 2020. e-Pub 2020. PMID: 33459402.
87. Boxerman JL, Quarles CC, Hu LS, Erickson BJ, Gerstner ER, Smits M, Kaufmann TJ, Barboriak DP, Huang RH, Wick W, Weller M, Galanis E, Kalpathy-Cramer J, Shankar L, Jacobs P, Chung C, van den Bent MJ, Chang S, Al Yung WK, Cloughesy TF, Wen PY, Gilbert MR, Rosen BR, Ellingson BM, Schmainda KM, Steering Committee JBTDDCIS. Consensus Recommendations for a Dynamic Susceptibility Contrast MRI Protocol for Use in High-Grade Gliomas. Neuro Oncol 22(9):1262-1275, 2020. e-Pub 2020. PMID: 32516388.
88. Slagowski JM, Ding Y, Aima M, Wen Z, Fuller CD, Chung C, Debnam JM, Hwang KP, Kadbi M, Szklaruk J, Wang J. A modular phantom and software to characterize 3D geometric distortion in MRI. Phys Med Biol 65(19):195008, 2020. e-Pub 2020. PMID: 32531763.
89. Tseng CL, Stewart J, Whitfield G, Verhoeff JJC, Bovi J, Soliman H, Chung C, Myrehaug S, Campbell M, Atenafu EG, Heyn C, Das S, Perry J, Ruschin M, Sahgal A. Glioma consensus contouring recommendations from a MR-Linac International Consortium Research Group and evaluation of a CT-MRI and MRI-only workflow. J Neurooncol 149(2):305-314, 2020. e-Pub 2020. PMID: 32860571.
90. Anakwenze CP, McGovern S, Taku N, Liao K, Boyce-Fappiano DR, Kamiya-Matsuoka C, Ghia A, Chung C, Trifiletti D, Ferguson SD, Li J, Yeboa DN. Association between Facility Volume and Overall Survival for Patients with Grade II Meningioma after Gross Total Resection. World Neurosurg 141:e133-e144, 2020. e-Pub 2020. PMID: 32407910.
91. Jain AK, Aneja S, Fuller CD, Dicker AP, Chung C, Kim E, Kirby JS, Quon H, Lam CJK, Louv WC, Ahern C, Xiao Y, McNutt TR, Housri N, Ennis RD, Kang J, Tang Y, Higley H, Berny-Lang MA, Camphausen KA. Provider Engagement in Radiation Oncology Data Science: Workshop Report. JCO Clin Cancer Inform 4:700-710, 2020. PMID: 32755458.
92. Noticewala SS, Ludmir EB, Bishop AJ, Chung C, Ghia AJ, Grosshans D, McGovern S, Paulino AC, Wang C, Woodhouse KD, Yeboa DN, Prabhu SS, Weathers SP, Das P, Koong AC, McAleer MF, Li J. Radiation for Glioblastoma in the Era of Coronavirus Disease 2019 (COVID-19): Patient Selection and Hypofractionation to Maximize Benefit and Minimize Risk. Adv Radiat Oncol 5(4):743-745, 2020. e-Pub 2020. PMID: 32775785.
93. Zaid M, Koay EJ, Bajaj N, Mathew R, Xiao L, Agrawal A, Fernandes P, Burrows H, Roach MA, Wilke CT, Chung C, Fuller CD, Phan J, Gunn GB, Morrison WH, Garden AS, Frank SJ, Rosenthal DI, Andersen M, Otun A, Chambers MS. A prospective parallel design study testing non-inferiority of customized oral stents made using 3D printing or manually fabricated methods. Oral Oncol 106:104665, 2020. e-Pub 2020. PMID: 32298994.
94. Kaufmann TJ, Smits M, Boxerman J, Huang R, Barboriak DP, Weller M, Chung C, Tsien C, Brown PD, Shankar L, Galanis E, Gerstner E, van den Bent MJ, Burns TC, Parney IF, Dunn G, Brastianos PK, Lin NU, Wen PY, Ellingson BM. Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases (BTIP-BM). Neuro Oncol 22(6):757-772, 2020. PMID: 32048719.
95. Patel RR, Verma V, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Mainwaring W, Augustyn A, Fuller CD, Sulman EP, Yeboa DN, Chung CC, McAleer MF, Li J, Yoshor D, de Groot JF, Mandel JJ, Ludmir EB. Exclusion of Patients with Brain Metastases from Cancer Clinical Trials. Neuro Oncol 22(4):577-579, 2020. e-Pub 2020. PMID: 31900480.
96. Buszek SM, Al Feghali KA, Elhalawani H, Chevli N, Allen PK, Chung C. Optimal Timing of Radiotherapy Following Gross Total or Subtotal Resection of Glioblastoma: A Real-World Assessment using the National Cancer Database. Sci Rep 10(1):4926, 2020. e-Pub 2020. PMID: 32188907.
97. Jin Y, Randall JW, Elhalawani H, Feghali KAA, Elliott AM, Anderson BM, Lacerda L, Tran BL, Mohamed AS, Brock KK, Fuller CD, Chung C. Detection of Glioblastoma Subclinical Recurrence Using Serial Diffusion Tensor Imaging. Cancers (Basel) 12(3), 2020. e-Pub 2020. PMID: 32121471.
98. McTyre ER, Soike MH, Farris M, Ayala-Peacock DN, Hepel JT, Page BR, Shen C, Kleinberg L, Contessa JN, Corso C, Chiang V, Henson-Masters A, Cramer CK, Ruiz J, Pasche B, Watabe K, D'Agostino R, Su J, Laxton AW, Tatter SB, Fiveash JB, Ahluwalia M, Kotecha R, Chao ST, Braunstein SE, Attia A, Chung C, Chan MD. Multi-institutional validation of brain metastasis velocity, a recently defined predictor of outcomes following stereotactic radiosurgery. Radiother Oncol 142:168-174, 2020. e-Pub 2019. PMID: 31526671.
99. Esho TO, Chung C, Thompson JU, Dehghanpour M, Sutton JR, Shaitelman SF, Kisling KK, Court LE. Optimization of autogenerated chest-wall radiation treatment plans developed for postmastectomy breast cancer patients in underserved clinics. Med Dosim 45(1):102-107, 2020. e-Pub 2020. PMID: 31956001.
100. Whelan TJ, Julian JA, Berrang TS, Kim DH, Germain I, Nichol AM, Akra M, Lavertu S, Germain F, Fyles A, Trotter T, Perera FE, Balkwill S, Chafe S, McGowan T, Muanza T, Beckham WA, Chua BH, Gu CS, Levine MN, Olivotto IA, Investigators RT. External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial. Lancet 394(10215):2165-2172, 2019. e-Pub 2019. PMID: 31813635.
101. Thomas D, Chung C, Zhang Y, Te A, Gratzke C, Woo H, Chughtai B. Clinical Trials in Benign Prostatic Hyperplasia: A Moving Target of Success. Eur Urol Focus 5(6):1101-1104, 2019. e-Pub 2018. PMID: 29804815.
102. Milgrom SA, Varghese B, Gladish GW, Choi AD, Dong W, Patel ZS, Chung CC, Rao A, Pinnix CC, Gunther JR, Dabaja BS, Lin SH, Hoffman KE, Huff JL, Slagowski J, Abe JI, Iliescu CA, Banchs J, Yusuf SW, Lopez-Mattei JC. Coronary Artery Dose-Volume Parameters Predict Risk of Calcification After Radiation Therapy. J Cardiovasc Imaging 27(4):268-279, 2019. PMID: 31614398.
103. Kuhn T, Jin Y, Huang C, Kim Y, Nir TM, Gullett JM, Jones JD, Sayegh P, Chung C, Dang BH, Singer EJ, Shattuck DW, Jahanshad N, Bookheimer SY, Hinkin CH, Zhu H, Thompson PM, Thames AD. The Joint Effect of Aging and HIV Infection on Microstructure of White Matter Bundles. Hum Brain Mapp 40(15):4370-4380, 2019. e-Pub 2019. PMID: 31271489.
104. Hughes RT, Masters AH, McTyre ER, Farris MK, Chung C, Page BR, Kleinberg LR, Hepel J, Contessa JN, Chiang V, Ruiz J, Watabe K, Su J, Fiveash JB, Braunstein S, Chao S, Attia A, Ayala-Peacock DN, Chan MD. Initial SRS for Patients With 5 to 15 Brain Metastases: Results of a Multi-Institutional Experience. Int J Radiat Oncol Biol Phys 104(5):1091-1098, 2019. e-Pub 2019. PMID: 30959122.
105. Zaid M, Bajaj N, Burrows H, Mathew R, Dai A, Wilke CT, Palasi S, Hergenrother R, Chung C, Fuller CD, Phan J, Gunn GB, Morrison WH, Garden AS, Frank SJ, Rosenthal DI, Andersen M, Otun A, Chambers MS, Koay EJ. Creating customized oral stents for head and neck radiotherapy using 3D scanning and printing. Radiat Oncol 14(1):148, 2019. e-Pub 2019. PMID: 31426824.
106. Ludmir EB, Mahajan A, Ahern V, Ajithkumar T, Alapetite C, Bernier-Chastagner V, Bindra RS, Bishop AJ, Bolle S, Brown PD, Carrie C, Chalmers AJ, Chang EL, Chung C, Dieckmann K, Esiashvili N, Gandola L, Ghia AJ, Gondi V, Grosshans DR, Harrabi SB, Horan G, Indelicato DJ, Jalali R, Janssens GO, Krause M, Laack NN, Laperriere N, Laprie A, Li J, Marcus KJ, McGovern SL, Merchant TE, Merrell KW, Padovani L, Parkes J, Paulino AC, Schwarz R, Shih HA, Souhami L, Sulman EP, Taylor RE, Thorp N, Timmermann B, Wheeler G, Wolden SL, Woodhouse KD, Yeboa DN, Yock TI, Kortmann RD, McAleer MF. Assembling the brain trust: the multidisciplinary imperative in neuro-oncology. Nat Rev Clin Oncol 16(8):521-522, 2019. PMID: 31150024.
107. Bliesener Y, Zhong X, Guo Y, Boss M, Bosca R, Laue H, Chung C, Sung K, Nayak KS. Radiofrequency transmit calibration: A multi-center evaluation of vendor-provided radiofrequency transmit mapping methods. Med Phys 46(6):2629-2637, 2019. e-Pub 2019. PMID: 30924940.
108. Kwan JYY, Croke J, Panzarella T, Ubhi K, Fyles A, Koch A, Dinniwell R, Levin W, McCready D, Chung C, Liu F, Bender JL. Personalizing Post-Treatment Cancer Care: A Cross-Sectional Survey Examining the Needs and Preferences of Well Breast Cancer Survivors. Current Oncology. e-Pub 2019. PMID: 31043819.
109. Buszek SM, Ikner S, Wiedemann L, Wang J, McAleer MF, Grosshans DR, Paulino AC, McGovern SL, Chung C. Safety and Feasibility of Magnetic Resonance Imaging Simulation for Radiation Treatment Planning in Pediatric Patients: A Single Institution Experience. Adv Radiat Oncol 4(2):362-366, 2019. e-Pub 2018. PMID: 31011682.
110. Coolens C, Driscoll B, Foltz W, Svistoun I, Sinno N, Chung C. Unified platform for multimodal voxel-based analysis to evaluate tumour perfusion and diffusion characteristics before and after radiation treatment evaluated in metastatic brain cancer. Br J Radiol 92(1096):20170461, 2019. e-Pub 2019. PMID: 30235004.
111. Foltz W, Driscoll B, Laurence Lee S, Nayak K, Nallapareddy N, Fatemi A, Ménard C, Coolens C, Chung C. Phantom Validation of DCE-MRI Magnitude and Phase-Based Vascular Input Function Measurements. Tomography 5(1):77-89, 2019. PMID: 30854445.
112. Moraes FY, Winter J, Atenafu EG, Dasgupta A, Raziee H, Coolens C, Millar BA, Laperriere N, Patel M, Bernstein M, Kongkham P, Zadeh G, Conrad T, Chung C, Berlin A, Shultz DB. Outcomes following stereotactic radiosurgery for small to medium-sized brain metastases are exceptionally dependent upon tumor size and prescribed dose. Neuro Oncol 21(2):242-251, 2019. PMID: 30265328.
113. Majd NK, Metrus NR, Santos-Pinheiro F, Trevino CR, Fuller GN, Huse JT, Chung C, Ketonen L, Anderson MD, Penas-Prado M. RBM10 Truncation in Astroblastoma in a Patient with History of Mandibular Ameloblastoma: A case report. Cancer Genet 231-232:41-45, 2019. e-Pub 2019. PMID: 30803556.
114. Yeboa DN, Liao KP, Guadagnolo BA, Rao G, Bishop A, Chung C, Li J, Tatsui CE, Rhines LD, Ferguson S, Paulino AC, Ghia AJ. National Patterns of Care in the Management of WHO Grade II and III Spinal Ependymomas. World Neurosurg. e-Pub 2019. PMID: 30641236.
115. Papadakos J, Agarwal A, Charow R, Quartey NK, D'souza A, Giuliani M, Millar BA, Massey C, Shultz D, Chung C. Informational needs of brain metastases patients and their caregivers. Neurooncol Pract 6(1):47-60, 2019. e-Pub 2018. PMID: 31386069.
116. Sandström H, Jokura H, Chung C, Toma-Dasu I. Multi-institutional study of the variability in target delineation for six targets commonly treated with radiosurgery. Acta Oncol 57(11):1-6, 2018. e-Pub 2018. PMID: 29786462.
117. Sandstrom H, Jokura H Chung C, Yoma-Dasu I. Simultaneous truth and performance level estimation method for evaluation of target contouring in radiosurgery - feasibility test and robustness analysis. Acta Oncologica 57(11):1515-1520, 2018. PMID: 29786462.
118. Moraes FY, Winter J, Atenafu EG, Dasgputa A, Raziee H, Coolens C, Millar BA, Laperriere N, Patel M, Bernstein M, Kongkham P, Zadeh G, Conrad T, Chung C, Berlin A, Shultz DB. Outcomes following SRS for small- to medium-sized brain metastases are exceptionally dependent upon tumor size and prescribed dose. Neuro Oncol. e-Pub 2018. PMID: None.
119. Cao C, Huang J, Rimner A, Wang D, Chung C, Jones DR. Stereotactic Body Radiation Therapy: Focusing on the Short Game. J Clin Oncol 36(23):2455-2456, 2018. e-Pub 2018. PMID: 29863976.
120. Al Feghali KA, Hilal L, Chung C. Review of Intracranial Meningiomas: An Update on Management from Diagnosis to Treatment. Internal Medicine Review, 2018. PMID: None.
121. Head J, Development Cooperative NR. Publisher Correction: A Multi-Institutional Comparison of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Parameter Calculations. Sci Rep 8(1):4422, 2018. e-Pub 2018. PMID: 29520065.
122. Head J, Development Cooperative NR. Erratum: Dynamic contrast-enhanced magnetic resonance imaging for head and neck cancers. Sci Data 5:180041, 2018. e-Pub 2018. PMID: 29557974.
123. Head J, Development Cooperative NR. Dynamic contrast-enhanced magnetic resonance imaging for head and neck cancers. Sci Data 5:180008, 2018. e-Pub 2018. PMID: 29437167.
124. McTyre E, Ayala-Peacock D, Contessa J, Corso C, Chiang V, Chung C, Fiveash J, Ahluwalia M, Kotecha R, Chao S, Attia A, Henson A, Hepel J, Braunstein S, Chan M. Multi-Institutional Competing Risks Analysis of Distant Brain Failure and Salvage Patterns after Upfront Radiosurgery without Whole Brain Radiotherapy for Brain Metastasis. Ann Oncol 29(2):497-503, 2018. e-Pub 2017. PMID: 29161348.
125. Winter JD, Moraes FY, Chung C, Coolens C. Detectability of radiation-induced changes in magnetic resonance biomarkers following stereotactic radiosurgery: A pilot study. PLoS One 13(11):e0207933, 2018. e-Pub 2018. PMID: 30475887.
126. Churilla TM, Ballman KV, Brown PD, Twohy EL, Jaeckle K, Farace E, Cerhan JH, Anderson SK, Carrero XW, Garces YI, Barker FG, Deming R, Dixon JG, Burri SH, Chung C, Ménard C, Stieber VW, Pollock BE, Galanis E, Buckner JC, Asher AL. Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled Trial. Int J Radiat Oncol Biol Phys 99(5):1173-1178, 2017. e-Pub 2017. PMID: 28939223.
127. Hahn E, Laperriere N, Krema H, Velazquez-Martin JP, Somani S, Waldron J, Simpson R, Payne D, Chung C. Clinical outcomes of hypofractionated radiation therapy for choroidal metastases: Symptom palliation, tumor control, and survival. Pract Radiat Oncol 7(6):388-395, 2017. e-Pub 2017. PMID: 28867543.
128. Chung C, Brock K. Image-guided radiation therapy: looking beyond what we currently see. Future Oncol 13(26):2317-2319, 2017. e-Pub 2017. PMID: 29121781.
129. Ayala-Peacock DN, Attia A, Braunstein SE, Ahluwalia MS, Hepel J, Chung C, Contessa J, McTyre E, Peiffer AM, Lucas JT, Isom S, Pajewski NM, Kotecha R, Stavas MJ, Page BR, Kleinberg L, Shen C, Taylor RB, Onyeuku NE, Hyde AT, Gorovets D, Chao ST, Corso C, Ruiz J, Watabe K, Tatter SB, Zadeh G, Chiang VLS, Fiveash JB, Chan MD. Prediction of New Brain Metastases after Radiosurgery: Validation and Analysis of Performance of a Multi-Institutional Nomogram. J Neurooncol 135(2):403-411, 2017. e-Pub 2017. PMID: 28828698.
130. Raziee H, Moraes F, Cho YB, Maganti M, Shultz D, Millsr BA, Laperriere N, Berlin A, Chung C. Assessment of Dosimetric Predictors and Impact of Whole-Brain Radiation Therapy on the Incidence of Radionecrosis after Stereotactic Radiosurgery for Brain Metastasis. Int J Radiat Oncol Biol Phys 99(2), 2017. PMID: None.
131. Ger RB, Mohamed ASR, Awan MJ, Ding Y, Li K, Fave XJ, Beers AL, Driscoll B, Elhalawani H, Hormuth DA, Houdt PJV, He R, Zhou S, Mathieu KB, Li H, Coolens C, Chung C, Bankson JA, Huang W, Wang J, Sandulache VC, Lai SY, Howell RM, Stafford RJ, Yankeelov TE, Heide UAV, Frank SJ, Barboriak DP, Hazle JD, Court LE, Kalpathy-Cramer J, Fuller CD. A multi-institutional comparison of dynamic contrast-enhanced magnetic resonance imaging parameter calculations. Sci Rep 7(1):11185, 2017. e-Pub 2017. PMID: 28894197.
132. Moraes FY, Chung C. Radiation for Skull Base Meningiomas: Review of the Literature on the Approach to Radiotherapy. Chin Clin Oncol 6((Suppl 1):S3):S3, 2017. PMID: 28758407.
133. Murray L, Longo J, Wan J, Chung C, Wang L, Dawson L, Milosevic M, Oza A, Brade A. Phase I dose escalation study of concurrent palliative radiation therapy with sorafenib in three anatomical cohorts (Thorax, Abdomen, Pelvis): The TAP study. Radiother Oncol 124(1):74-79, 2017. e-Pub 2017. PMID: 28668472.
134. McNamara MG, Jiang H, Lim-Fat MJ, Sahebjam S, Kiehl TR, Karamchandani J, Coire C, Chung C, Millar BA, Laperriere N, Mason WP. Treatment Outcomes in 1p19q Co-deleted/Partially Deleted Gliomas. Can J Neurol Sci 44(3):288-294, 2017. PMID: 28488951.
135. Mason M, Maurice C, McNamara MG, Tieu MT, Lwin Z, Millar BA, Menard C, Laperriere N, Milosevic M, Atenafu EG, Mason W, Chung C. Neutrophil-Lymphocyte Ratio Dynamics during Concurrent Chemo-radiotherapy for Glioblastoma is an Independent Predictor for Overall Survival. J Neurooncol 132(3):463-471, 2017. e-Pub 2017. PMID: 28332000.
136. Doherty MK, Korpanty GJ, Tomasini P, Alizadeh M, Jao K, Labbé C, Mascaux CM, Martin P, Kamel-Reid S, Tsao MS, Pintilie M, Liu G, Bradbury PA, Feld R, Leighl NB, Chung C, Shepherd FA. Treatment options for patients with brain metastases from EGFR/ALK-driven lung cancer. Radiother Oncol 123(2):195-202, 2017. e-Pub 2017. PMID: 28363487.
137. Perry JR, Laperriere N, O'Callaghan CJ, Brandes AA, Menten J, Phillips C, Fay M, Nishikawa R, Cairncross JG, Roa W, Osoba D, Rossiter JP, Sahgal A, Hirte H, Laigle-Donadey F, Franceschi E, Chinot O, Golfinopoulos V, Fariselli L, Wick A, Feuvret L, Back M, Tills M, Winch C, Baumert BG, Wick W, Ding K, Mason WP, Investigators T. Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma. N Engl J Med 376(11):1027-1037, 2017. PMID: 28296618.
138. Wilke CT, Zaid M, Chung C, Fuller CD, Mohamed ASR, Skinner H, Phan J, Gunn GB, Morrison WH, Garden AS, Frank SJ, Rosenthal DI, Chambers MS, Koay EJ. Design and fabrication of a 3D-printed oral stent for head and neck radiotherapy from routine diagnostic imaging. 3D Print Med 3(1):12, 2017. e-Pub 2017. PMID: 29782600.
139. Murray L, Menard C, Zadeh G, Au K, Bernstein M, Millar BA, Laperriere N, Chung C. Radiosurgery for brainstem metastases with and without whole brain radiotherapy: clinical series and literature review. J Radiat Oncol 6(1):1-10, 2017. e-Pub 2016. PMID: 28367275.
140. Coolens C, Driscoll B, Foltz W, Pellow C, Menard C, Chung C. Comparison of Voxel-Wise Tumor Perfusion Changes Measured With Dynamic Contrast-Enhanced (DCE) MRI and Volumetric DCE CT in Patients With Metastatic Brain Cancer Treated with Radiosurgery. Tomography 2(4):325-333, 2016. PMID: 30042966.
141. Sandström H, Chung C, Jokura H, Torrens M, Jaffray D, Toma-Dasu I. Assessment of organs-at-risk contouring practices in radiosurgery institutions around the world - The first initiative of the OAR Standardization Working Group. Radiother Oncol 121(2):180-186, 2016. e-Pub 2016. PMID: 27816408.
142. Li W, Cho YB, Ansell S, Laperriere N, Ménard C, Millar BA, Zadeh G, Kongkham P, Bernstein M, Jaffray DA, Chung C. The Use of Cone-Beam Computed Tomography for Image-Guided Gamma Knife Stereotactic Radiosurgery: Initial Clinical Evaluation. Int J Radiat Oncol Biol Phys 96(1):214-20, 2016. e-Pub 2016. PMID: 27511857.
143. Brown PD, Jaeckle K, Ballman KV, Farace E, Cerhan JH, Anderson SK, Carrero XW, Barker FG, Deming R, Burri SH, Ménard C, Chung C, Stieber VW, Pollock BE, Galanis E, Buckner JC, Asher AL. Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial. JAMA 316(4):401-409, 2016. PMID: 27458945.
144. Li W, Bootsma G, Von Schultz O, Carlsson P, Laperriere N, Millar BA, Jaffray D, Chung C. Preliminary Evaluation of a Novel Thermoplastic Mask System with Intra-fraction Motion Monitoring for Future Use With Image-Guided Gamma Knife. Cureus 8(3):e531, 2016. e-Pub 2016. PMID: 27081592.
145. Adilman R, Rajmohan Y, Brooks E, Urgoiti GR, Chung C, Hammad N, Trinkaus M, Naseem M, Simmons C, Adilman R, Rajmohan Y, Brooks E, Roldan Urgoiti G, Chung C, Hammad N, Trinkaus M, Naseem M, Simmons C. Social Media Use Among Physicians and Trainees: Results of a National Medical Oncology Physician Survey. J Oncol Pract 12(1):79-80, e52-60, 2016. e-Pub 2015. PMID: 26443837.
146. Cho YB, Laperriere N, Hodaie M, Chung C. Hybrid isocenter technique for Gamma-Knife Perfexion treatment of trigeminal neuralgia. Med Dosim 41(4):271-276, 2016. PMID: 27839588.
147. Li W, Cho YB, Ansell S, Laperriere N, Menard C, Millar BA, Zadeh G, Kongkham P, Bernstein M, Jaffray D, Chung C. Image-Guidance for Gamma Knife Stereotactic Radiosurgery Using Cone-Beam Computed Tomography. Int J Radiat Oncol Biol Phys 96(1):214-220, 2016. PMID: None.
148. Hussein H, Chung C, Moshonov H, Miller N, Kulkarni SR, Scaranelo AM. Evaluation of Apparent Diffusion Coefficient to Predict Grade, Microinvasion, and Invasion in Ductal Carcinoma In Situ of the Breast. Acad Radiol 22(12):1483-8, 2015. e-Pub 2015. PMID: 26391856.
149. Armstrong TS, Ying Y, Wu J, Acquaye AA, Vera-Bolanos E, Gilbert MR, Brown PD, Vardy J, Chung C. The Relationship between Corticosteroids and Symptoms in Patients with Primary Brain Tumors-Utility of the Dexamethasone Symptom Questionnaire-Chronic. Neuro Oncol 17(8):1114-1120, 2015. e-Pub 2015. PMID: 25862766.
150. Wazer DE, Hepel JT, Riker AI, Harness JK, Chung C, Khan AJ, Offersen BV, Poortmans P, Taghian A. In Regard to Vaidya et al. Int J Radiat Oncol Biol Phys 92(5):952-953, 2015. e-Pub 2015. PMID: 26194662.
151. Tieu MT, Lovblom LE, McNamara MG, Mason W, Laperriere N, Millar BA, Ménard C, Kiehl TR, Perkins BA, Chung C. Impact of glycemia on survival of glioblastoma patients treated with radiation and temozolomide. J Neurooncol 124(1):119-126, 2015. e-Pub 2015. PMID: 26015297.
152. Chung C, Torrens M, Paddick I, Ryu S, Hanssens P, Jaffray D. Radiosurgery Nomenclature: A Confusion of Tongues. Int J Radiat Oncol Biol Phys 25(3):119-126, 2015. PMID: 26068485.
153. Sahgal A, Chan MW, Atenafu EG, Masson-Cote L, Bahl G, Yu E, Millar BA, Chung C, Catton C, O’Sullivan B, Irish JC, Gilbert R, Zadeh G, Cusimano M, Gentili F, Laperriere NJ. Image-guided intensity modulated radiation therapy (IG-IMRT) for skull base chordoma and chondrosarcoma: preliminary outcomes. Neuro Oncol 17(6):889-94, 2015. PMID: None.
154. Coolens C, Driscoll B, Chung C, Shek T, Gorjizadeh A, Ménard C, Jaffray D. Automated Voxel-Based Analysis of Volumetric Dynamic Contrast-Enhanced CT Data Improves Measurement of Serial Changes in Tumor Vascular Biomarkers. Int J Radiat Biol Phys 91(1):48-57, 2015. PMID: 25446606.
155. Lymberiou T, Galuszka S, Lee G, Xu W, Su S, Fyles A, Purdie T, Catton P, Chung C, Dinniwell R, Han K, Koch A, Levin W, Manchul L, Sappiatzer J, Mackenzie P, Liu FF. Predictors of Breast Radiotherapy Plan Modifications: Quality Assurance Rounds in a Large Cancer Centre. Radiother Oncol 114(1):17-21, 2015. PMID: None.
156. Torrens M, Chung C, Chung HT, Hanssens P, Jaffray D, Kemeny A, Larson D, Levivier M, Lindquist C, Lippitz B, Novotny J, Paddick I, Prasad D, Yu CP. The standardization of terminology in stereotactic radiosurgery: report from the standardization committee of the International Leksell Gamma Knife®Society. J Neurosurg 121(Suppl):2-15, 2014. PMID: 25587587.
157. Hahn E, Laperriere N, Millar BA, Oestreicher J, McGowan H, Krema H, Gill H, DeAngelis D, Hurwitz J, Tucker N, Simpson R, Chung C. Orbital radiation therapy for Graves' ophthalmopathy: measuring clinical efficacy and impact. Pract Radiat Oncol 4(4):233-9, 2014. e-Pub 2014. PMID: 25012831.
158. Jalali S, Chung C, Foltz W, Burrell K, Singh S, Hill R, Zadeh G. MRI biomarkers identify the differential response of glioblastoma multiforme to anti-angiogenic therapy. NeuroOncology 16(6):868-79, 2014. e-Pub 2014. PMID: 24759636.
159. Mackenzie P, Fyles A, Wang W, Chung C. Advanced radiotherapy techniques for breast cancer to minimize cardiovascular risk. Breast Cancer Management 3(3):297-305, 2014. PMID: 21237584.
160. McNamara MG, Lwin Z, Jiang H, Templeton AJ, Zadeh G, Bernstein M, Chung C, Millar BA, Laperriere N, Mason WP. Factors impacting survival following second surgery in patients with glioblastoma in the temozolomide treatment era, incorporating neutrophil/lymphocyte ratio and time to first progression. J Neurooncol 117(1):147-52, 2014. PMID: None.
161. McNamara MG, Lwin Z, Jiang H, Chung C, Millar BA, Sahgal A, Laperriere N, Mason WP. Conditional probability of survival and post-progression survival in patients with glioblastoma in the temozolomide treatment era. J Neurooncol 117(1):153-60, 2014. PMID: None.
162. Kurtz G, Zadeh G, Gingras-Hill G, Millar BA, Laperriere NJ, Bernstein M, Jiang H, Ménard C, Chung C. Salvage radiosurgery for brain metastases: prognostic factors to consider in patient selection. Int J Radiat Oncol Biol Phys 88(1):137-42, 2014. PMID: None.
163. Tieu MT, Lovblom LE, MacNamara M, Mason W, Kiehl R, Rodin D, Laperriere N, Millar BA, Menard C, Perkins B, Chung C. Glycemia Impacts Survival of Glioblastoma Patients Treated with Radiation and Temozolomide. Journal of Neurooncology, 2014. PMID: None.
164. Hahn E, Velazquez-Martin JP, Somani S, Payne D, Waldron J, Krema H, Simpson R, Laperriere N, Chung C. Palliative radiotherapy for choroidal metastases: Clinical outcomes and predictors of overall survival. Practical Radiation Oncology 4(4):233-9, 2014. PMID: None.
165. Chung C, Mason. Salvage radiosurgery for high grade glioma in the era of modern systemic therapy. Can J Neurol Sci 40(6):761-2, 2013. PMID: None.
166. Krema H, Herrmann E, Albert-Green A, Payne D, Laperriere N, Chung C. Orthovoltage Radiotherapy in the Management of Medical Canthal Basal Cell Carcinoma. Br J Opthalmology 97(6):730-4, 2013. PMID: None.
167. Little A, Chung C, Perez-Ordonez B, Mikulis D, Valiante TA. High-grade intracranial chondrosarcoma presenting with haemorrhage. J Clin Neurosci 97(6):730-4, 2013. PMID: None.
168. Ebinu JO, Lwu S, Monsalves E, Arayee M, Chung C, Laperriere NJ, Kulkarni AV, Goetz P, Zadeh G. Gamma Knife Radiosurgery for the Treatment of Cystic Cerebral Metastases. Int J Radiat Oncol Biol Phys 85(3):667-71, 2013. e-Pub 2012. PMID: 22885145.
169. Chung C, Jalali S, Foltz W, Burrell K, Wildgoose P, Lindsay P, Graves C, Camphausen K, Milosevic M, Jaffray D, Zadeh G, Ménard C. Imaging Biomarker Dynamics in an Intracranial Murine Glioma Study of Radiation and Antiangiogenic Therapy. Int J Radiat Oncol Biol Phys 85(3):805-12, 2013. e-Pub 2012. PMID: 22929856.
170. Lwu S, Goetz P, Monsalves E, Aryaee M, Ebinu J, Laperriere N, Menard C, Chung C, Millar BA, Kulkarni AV, Bernstein M, Zadeh G. Stereotactic radiosurgery for the treatment of melanoma and renal cell carcinoma brain metastases. Oncol Rep 29(2):407-12, 2013. e-Pub 2012. PMID: 23151681.
171. Ruschin M, Komljenovic PT, Ansell S, Ménard C, Bootsma G, Cho YB, Chung C, Jaffray D. Cone Beam Computed Tomography Image Guidance System for a Dedicated Intracranial Radiosurgery Treatment Unit. Int J Radiat Oncol Biol Phys 85(1):243-250, 2013. e-Pub 2012. PMID: 22560556.
172. Ruschin M, De Jean P, Ansell S, Bootsma G, Chung C, Ménard C, Cho YB, Jaffray DA. Initial performance characterization and clinical implementation of a novel image-guided system for Perfexion. J Neurosurg, 2013. PMID: None.
173. Heydarian M, Wilson G, van Prooijen M, Cho Y, Krema H, Tamerou M, Chung C, Laperriere N, Jaffray D. A Non-invasive Eye Fixation and Monitoring System for the Treatment of Choroidal Melanoma (CM) Using Gamma-knife (GK) Radiosurgery. Int. J. Radiat. Oncol. Biol. Phys 84(3):S285, 2012. PMID: None.
174. Chung C, Tsao M, Lutz S. Conventional radiation therapy for brain metastases. J Radiat Oncol 1(3):211-219, 2012. PMID: None.
175. Chung C. Impact of Internal Mammary Node Irradiation in High-Risk Patients. Oncology Exchange 10(4):4-5, 2011. PMID: None.
176. Ibrahim GM, Chung C, Bernstein M. Competing for patients: an ethical framework for recruiting patient with brain tumors into clinical trials. J Neuro-oncol 104(3):623-7, 2011. PMID: 21318320.
177. Chung C, Brade A. Radiosensitizers and anti-angiogenic agents for brain metastases. Journal of Pain Management 4(2):149-158, 2010. PMID: None.
178. Chung C, Dawson L, Joshua A, Brade A. Radiation Recall Dermatitis Triggered by Multi Tyrosine Kinase Inhibitors: Sunitinib and Sorafenib. Anti-Cancer Drugs 21(2):209-209, 2010. PMID: 19952730.
179. Chung C, Al Ali J, Owen DA, Weiss AA, Yoshida EM, Tai IT. A rare case of isolated duodenal metastases from hepatocellular carcinoma associated with p53 and ki-67 expression: a case report. Cases J 2:9344, 2009. e-Pub 2009. PMID: 20062599.
180. Chung C, Al Ali J, Owen D, Weiss A, Yoshida E, Tai I. Slivers of Liver in the Distal Duodenum: A Rare Cause of Gastrointestinal Bleeding from Metastatic Hepatocellular Carcinoma. Cases Journal 2(9344), 2009. PMID: None.
181. Chung C, Stuart D, Keyes M. Radiation Recall Reaction Induced by Adjuvant Trastuzumab (Herceptin). Case Rep Med 2009(307894), 2009. PMID: 19746202.
182. Berthelet E, Germain F, Chung C, Kumar D, Larsson S, Wong F, Kader H. Accelerated-simultaneous boost IMRT for locally advanced head and neck cancer: Analysis of outcomes and patterns of failure. Radiother Oncol 82:46-47, 2007. PMID: None.
183. Chasen N, Gule-Monroe M, Taylor B, Hou P, Wintermark M, Stafford R, Chung C, Liu H. Validation of a low flip angle DSC-MRIperfusion protocol for brain tumorevaluation at 1.5T. American Society of Neuroradiology. PMID: None.
184. MD MSc DST, Mohammad M Khandwala MD, Liu PhD ZA, PhD NR, Shen G, Angela Sekely MA, Bernstein PhD LJ, Simpson R, Warren Mason MD, MD MSc CC, MD PhD FYDM, MBChB PhD LM, MD PhD DS, Normand Laperriere MD, MBChB BM, PhD KE. Neurocognitive performance in adults treated with radiation for a primary brain tumour. Advances in Radiation Oncology. PMID: None.
185. ADDED TO. PLACE HOLDER. British Journal of Anesthesia. PMID: None.
186. HOLDER P. Generative Adversarial Networks in the Medical Imaging Domain: A Study on Evaluation Measures. Scientific Reports. PMID: None.
187. Kotla S, Zhang A, Imanishi M, Ko KA, Lin SH, Gi YJ, Moczygemba M, Isgandarova S, Schadler KL, Chung C, Milgrom SA, Banchs J, Yusuf SW, Amaya DN, Guo H, Thomas TN, Shen YH, Deswal A, Hermann J, Kleinerman ES, Entman ML, Cooke JP, Schifitto G, Maggirwar SB, McBeath E, Gupte AA, Krishnan S, Patel ZS, Yoon Y, Burks JK, Fujiwara K, Brookes PS, Le N, Hamilton DJ, Abe J. Nicotinamide Adenine Dinucleotide (NAD+) Depletion-induced Mitochondrial Hibernation Triggers Senescence-Associated Secretory Phenotype in Myeloid Cells after Chemo-radiation. Cell Metabolism. PMID: None.
188. Naseem M, Barzi A, Brezden-Masley C, Chung C, Puccini A, Berger MD, Tokunaga R, Battaglin F, Soni S, McSkane M, Zhang W, Lenz H. Ebstein-Barr virus associated gastric cancer: a comprehensive review. Cancer Res. PMID: None.
189. Kwan JYY, Croke J, Panzarella T, Ubhi K, Liu FF, Fyles A, Koch A, Dinniwell R, Levin W, McCready D, Chung C, Bender J. Supportive Care Needs and Perceptions of Alternative Follow-up Care Options Among Well Breast Cancer Patients: A Cross-sectional Survey. Journal of Cancer Survivorship. PMID: None.
190. Martin GV, Butner MD, Wang Z, Corradetti B, Ferrari M, Esnaola N, Chung C, Hong D, Welsh JW, Hasegawa N, Mittendorf EA, Curley SA, Chen SH, Pan PY, Chen HM, Pasqualini R, Arap W, Sidman RL, Koay EJ, Cristini V. Early prediction of maximal response to checkpoint inhibitor therapy in human solid cancers through mathematical modeling. Proceedings of the National Academy of Sciences (PNAS). PMID: None.
191. McCullum L, Wood J, Gule-Monroe M, Liu HA, Chen M, Shah K, Chasen NN, Kumar V, Hou P, Stafford J, Chung C, Ahmad M, Walker C, Yung J. The Use of Quantitative Metrics and Machine Learning to Predict Radiologist Interpretations of MRI Image Quality and Artifacts. Medical Physics Journal. PMID: None.

Invited Articles

1. Sammons S, Van Swearingen AED, Chung C, Anders CK. Advances in the Management of Breast Cancer Brain Metastases. Neurooncol Adv 3(Suppl 5):v63-v74, 2021. e-Pub 2021. PMID: 34859234.
2. Chung C, Kalpathy-Cramer J, Knopp MV, Jaffray DA. In the era of deep learning, why reconstruct an image at all?. J Am Coll Radiol 18(1 Pt B):170-173, 2021. PMID: 33413895.
3. Chung C. Unique Glioma Requiring Unique Management. Int J Radiat Oncol Biol Phys 108(3):520-521, 2020. PMID: 32976781.
4. Jaffray DA, Chung C, Coolens C, Foltz W, Keller H, Menard C, Milosevic M, Publicover J, Yeung I. Quantitative imaging in radiation oncology: An emerging science and clinical service. Semin Radiat Oncol 25(4):292-304, 2015. e-Pub 2015. PMID: 26384277.
5. Chung C, Laperriere N. How I treat glioblastoma. Clinical Practice 10(2):157-65, 2013. PMID: None.

Manuals, Teaching Aids, Other Teaching Publications

1. Chung C. New Hope for Brain Metastases. Connexions. None, 2010.

Other Articles

1. Yankeelov TE, Hormuth DA, EABF L, Lorenzo G, Wu C, Okereke LC, Rauch GM, Venkatesan AM, Chung C Designing clinical trials for patients who are not average. iScience 27(1):108589, 2024. PMID: 38169893.
2. Guckenberger M, Andratschke N, Chung C, Fuller D, Tanadini-Lang S, Jaffray DA The Future of MR-Guided Radiation Therapy. Semin Radiat Oncol 34(1):135-144, 2024. PMID: 38105088.
3. Kim MM, Mehta MP, Smart DK, Steeg PS, Hong JA, Espey MG, Prasanna PG, Crandon L, Hodgdon C, Kozak N, Armstrong TS, Morikawa A, Willmarth N, Tanner K, Boire A, Gephart MH, Margolin KA, Hattangadi-Gluth J, Tawbi H, Trifiletti DM, Chung C, Basu-Roy U, Burns R, Oliva ICG, Aizer AA, Anders CK, Davis J, Ahluwalia MS, Chiang V, Li J, Kotecha R, Formenti SC, Ellingson BM, Gondi V, Sperduto PW, Barnholtz-Sloan JS, Rodon J, Lee EQ, Khasraw M, Yeboa DN, Brastianos PK, Galanis E, Coleman CN, Ahmed MM National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities. Lancet Oncol 24(8):e344-e354, 2023. PMID: 37541280.
4. Baroudi H, Brock KK, Cao W, Chen X, Chung C, Court LE, El Basha MD, Farhat M, Gay S, Gronberg MP, Gupta AC, Hernandez S, Huang K, Jaffray DA, Lim R, Marquez B, Nealon K, Netherton TJ, Nguyen CM, Reber B, Rhee DJ, Salazar RM, Shanker MD, Sjogreen C, Woodland M, Yang J, Yu C, Zhao Y Automated Contouring and Planning in Radiation Therapy: What Is 'Clinically Acceptable'?. Diagnostics (Basel) 13(4), 2023. PMID: 36832155.
5. Lu SC, Swisher CL, Chung C, Jaffray D, Sidey-Gibbons C On the importance of interpretable machine learning predictions to inform clinical decision making in oncology. Front Oncol 13:1129380, 2023. PMID: 36925929.
6. Butner, JD, Dogra, P, Chung, C, Pasqualini, R, Arap, W, Lowengrub, JS, Cristini, V, Wang, Z Mathematical modeling of cancer immunotherapy for personalized clinical translation. Nature Computational Science 2(12):785-796, 2022. PMID: 38126024.
7. Guran E, Hu J, Wefel JS, Chung C, Cata JP Perioperative considerations in patients with chemotherapy-induced cognitive impairment: a narrative review. Br J Anaesth 129(6):909-922, 2022. PMID: 36270848.
8. Hormuth DA, Farhat M, Christenson C, Curl B, Chad Quarles C, Chung C, Yankeelov TE Opportunities for improving brain cancer treatment outcomes through imaging-based mathematical modeling of the delivery of radiotherapy and immunotherapy. Adv Drug Deliv Rev 187:114367, 2022. PMID: 35654212.
9. Wu C, Lorenzo G, Hormuth DA, EABF L, Slavkova KP, DiCarlo JC, Virostko J, Phillips CM, Patt D, Chung C, Yankeelov TE Integrating mechanism-based modeling with biomedical imaging to build practical digital twins for clinical oncology. Biophys Rev (Melville) 3(2):021304, 2022. PMID: 35602761.
10. Ding, Yao, Meheissen, Mohamed, Zhou, Kun, Mohamed, Abdallah, Wen, Zhifei, Ng, Sweet, Elhalawani, Hesham, Elgohari, Baher, Hutcheson, Katherine, Chung, Caroline, Lai, Stephen, Fuller, Clifton, Wang, Jihong Evaluation of different diffusion-weighted image techniques for head and neck radiation treatment: phantom and volunteer studies. None, 2022. PMID: None.
11. Charalel RA, Sung J, Askin G, Jo J, Mitry M, Chung C, Tmanova L, Madoff DC Systematic Reviews and Meta-Analyses of Portal Vein Embolization, Associated Liver Partition and Portal Vein Ligation, and Radiation Lobectomy Outcomes in Hepatocellular Carcinoma Patients. Curr Oncol Rep 23(11):135, 2021. PMID: 34716800.
12. Massaad E, Hamidi N, Goetz J, Padmanaban V, Mau C, Tsang D, de Moraes FY, Chung C, Zacharia BE, Mansouri A Equivalent efficacy and safety of radiosurgery for cystic and solid vestibular schwannomas: A systematic review. World Neurosurg 146:322-331.e1, 2021. PMID: 33212274.
13. Zakaria R, Radon M, Mills S, Mitchell D, Palmieri C, Chung C, Jenkinson MD The Role of the Immune Response in Brain Metastases: Novel Imaging Biomarkers for Immunotherapy. Front Oncol 11:711405, 2021. PMID: 34765539.
14. Shukla-Dave A, Obuchowski NA, Chenevert TL, Jambawalikar S, Schwartz LH, Malyarenko D, Huang W, Noworolski SM, Young RJ, Shiroishi MS, Kim H, Coolens C, Laue H, Chung C, Rosen M, Boss M, Jackson EF Quantitative Imaging Biomarkers Alliance (QIBA) Recommendations for Improved Precision of DWI and DCE-MRI Derived Biomarkers in Multicenter Oncology Trials. J Magn Reson Imaging 49(7):e101-e121, 2019. PMID: 30451345.
15. Cao C, Wang D, Chung C, Tian D, Rimner A, Huang J, Jones DR A systematic review and meta-analysis of stereotactic body radiation therapy versus surgery for patients with non-small cell lung cancer. J Thorac Cardiovasc Surg 157(1):362-373.e8, 2019. PMID: 30482524.
16. Patel A, Dong T, Ansari S, Cohen-Gadol A, Watson GA, Moraes FY, Nakamura M, Murovic J, Chang SD, Hatiboglu MA, Chung C, Miller JC, Lautenschlaeger T Toxicity of Radiosurgery for Brainstem Metastases. World Neurosurg 119:e757-e764, 2018. PMID: 30096494.
17. Chung C, Bryant A, Brown PD Interventions for the treatment of brain radionecrosis after radiotherapy or radiosurgery. Cochrane Database Syst Rev 7:CD011492, 2018. PMID: 29987845.
18. Al Feghali KA, Yeboa DN, Chasen B, Gule MK, Johnson JM, Chung C The Use of 68Ga-DOTATATE PET/CT in the Non-Invasive Diagnosis of Optic Nerve Sheath Meningioma: A Case Report. Front Oncol 8:454, 2018. PMID: 30386741.
19. Maqbool T, Agarwal A, Sium A, Trang A, Chung C, Papadakos J Informational and Supportive Care Needs of Brain Metastases Patients and Caregivers: a Systematic Review. J Cancer Educ 32(4):914-923, 2017. PMID: 27041700.
20. Ellingson BM, Chung C, Pope WB, Boxerman JL, Kaufmann TJ Pseudoprogression, radionecrosis, inflammation or true tumor progression? Challenges associated with glioblastoma response assessment in an evolving therapeutic landscape. J Neurooncol 10(3):2375-2, 2017. PMID: 28382534.
21. Kerbauy MN, Moraes FY, Lok BH, Ma J, Kerbauy LN, Spratt DE, Santos FP, Perini GF, Berlin A, Chung C, Hamerschlak N, Yahalom J Challenges and Opportunities in Primary CNS Lymphoma: a systematic review. Radiother Oncol 122(3):352-361, 2017. PMID: 28104300.
22. Ellingson BM, Bendszus M, Boxerman J, Barboriak D, Erickson BJ, Smits M, Nelson SJ, Gerstner E, Alexander B, Goldmacher G, Wick W, Vogelbaum M, Weller M, Galanis E, Kalpathy-Cramer J, Shankar L, Jacobs P, Pope WB, Yang D, Chung C, Knopp MV, Cha S, van den Bent MJ, Chang S, Yung WK, Cloughesy TF, Wen PY, Gilbert MR, Steering Committee JBTDDCIS Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials. Neuro Oncol 17(9):1188-98, 2015. PMID: 26250565.
23. Chung C, Metser U, Ménard C Advances in Magnetic Resonance Imaging and Positron Emission Tomography Imaging for Grading and Molecular Characterization of Glioma. Semin Radiat Oncol 25(3):164-71, 2015. PMID: 26050586.
24. Chung C, Laperriere N Radiation therapy and grade II/III oligodendroglial tumors. CNS Oncol 4(5):325-32, 2015. PMID: 26477980.
25. Chung C, Jaffray D Context is Everything: Foundational Data Management Principles to Realize IOM’s Learning Health System, Viewpoint. Lancet Digital Health. PMID: None.

Editorials

1. Chung, C, Buczkowicz, P. Editorial. Frontiers in Genetics 15, 2024. PMID: 39086473.
2. Chung C, Buczkowicz P. Editorial: Recent advances in the molecular genetics of glioma. Front Genet 15(None):1435186, 2024. PMID: 39086473.
3. Omary RA, Chung C, Lee CI. The Provocative: A Glimpse Into Radiology's Future. J Am Coll Radiol 18(1 Pt B):137-139, 2021. PMID: 33413889.
4. Tawbi HA, Chung C, Margolin K. Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain. N Engl J Med 379(22):2178, 2018. PMID: None.
5. Chung C, Prasad D, Torrens M, Paddick I, Hanssens P, Kondziolka D, Jaffray DA. Editorial: Leksell Gamma Knife Society and Radiosurgery: A legacy and a vision for the future. Journal of Neurosurgery Suppl(129):2-4, 2018. PMID: None.
6. Johnson JM, Chung C. Glioblastoma: does PET shed light to a difficult problem?. Translational Cancer Research 5(S4), 2016. PMID: None.
7. Wazer DE, Hepel JT, Riker AI, Harness JK, Chung C, Khan AJ, Offersen BV, Poortmans P, Taghian A. In Regard to Vadiya et al. International Journal of Radiation Oncology Biology Physics 92(5):952-953, 2015. PMID: None.
8. Mackenzie P, Fyles A, Chung C. Radiotherapy for breast cancer, the TARGIT-A trial. Lancet 383(9930):1717, 2014. PMID: None.
9. Ruschin M, Komljenovic PT, Ansell S, Ménard C, Bootsma G, Cho YB, Chung C, Jaffray D. In reply to Cheung. Int J Radiat Oncol Biol Phys 85(2):291-2, 2013. PMID: 23312270.
10. Lee SL, Chung C. Experience of Attending the 2012 Annual ISMRM Scientific Conference. Ontario Medical Students Association Scrub-In Magazine, 2012. PMID: None.

Abstracts

1. Hormuth II DA, Farhat M, Bronk J, Langshaw H, Curl B, Yankeelov TE, Chung C. Personalizaing spatial-temporal forecasts of high-grade glioma response to radiotherapy via multi-parameteric MRI. 12th European Conference on Mathematical and Theoretical Biology, 2022. PMID: None.
2. Wu C, Lorenzo G, Hormuth DA, EABF L, Slavkova KP, DiCarlo JC, Virostko J, Phillips CM, Patt D, Chung C, Yankeelov TE. Integrating mechanism-based modeling with biomedical imaging to build practical digital twins for clinical oncology. AIP Biophysics Reviews 3(2), 2022. PMID: None.
3. Butner JD, Wang Z, Elganainy D, Al Feghali KA, Plodinec M, Calin GA, Dogra P, Nizzero S, Ruiz-Ramírez J, Martin GV, Tawbi HA, Chung C, Koay EJ, Welsh JW, Hong DS, Cristini V. A mathematical model for the quantification of a patient's sensitivity to checkpoint inhibitors and long-term tumour burden. Nat Biomed Eng 5(4):297-308, 2021. e-Pub 2021. PMID: 33398132.
4. SandstrÖm H, Toma-Dasu I, Chung C, GÅrding J, Jokura H, Dasu A. Simultaneous Truth and Performance Level Estimation Method for Evaluation of Target Contouring in Radiosurgery. Anticancer Res 41(1):279-288, 2021. PMID: 33419822.
5. Tsang DSC, Khandwala M, Liu Z, Richard N, Bernstein L, Shen G, Simpson R, Chung C, Moraes F, Murray L, Shultz DB, Laperriere NJ, Millar BA, Mason WP, Edelstein K. Modelling Neurocognitive Change Using Brain Substructure Dosimetry In Adults With Primary Brain Tumors. Int. J. Radiat. Oncol. Biol. Phys 108(3):E717-E718, 2020. PMID: None.
6. Palmer J, Klamer B, Ballman K, Brown P, Cerhan J, Anderson K, Whitton A, Greenspoon J, Chung C, Burri S, Parney I, Stieber V, Pollock B, Laack N, Ashman J, Bahary JP, Barker F, Galanis E, Asher A, Roberge D. Effect of Stereotactic Radiosurgery Compared to Whole-brain Radiotherapy for Limited Brain Metastasis on Long Term Cognition and Quality of Life: A Pooled Analysis of Randomized Clinical Trials. Neuro Oncol 22(2):40-41, 2020. PMID: None.
7. Netherton TJ, Rhee DJ, Cardenas CE, Chung C, Klopp AH, Peterson CB, Howell RM, Balter PA, Court LE. Evaluation of a multiview architecture for automatic vertebral labeling of palliative radiotherapy simulation CT images. Med Phys 47(11):5592-5608, 2020. e-Pub 2020. PMID: 33459402.
8. Thrower S, Al Feghali KA, Luo D, Paddick I, Brock KK, Chung C. MR Slice Thickness Impacts Detection and Delineation of Brain Metastases for Treatment Determination, Radiosurgery Treatment Planning and Follow-Up. Int. J. Radiat. Oncol. Biol. Phys 108(3):E680-E680, 2020. PMID: None.
9. Augustyn A, Ludmir EB, Patel RR, Maldonado A, Bishop AJ, Chung C, Ghia AJ, McAleer MF, McGovern SL, Woodhouse KD, Yeboa DN, Briere TM, Haydu LE, Ferguson S, Guha-Thakurta N, Glitza I, Li J. Concurrent Immunotherapy and Stereotactic Radiosurgery for Patients with Melanoma Brain Metastases is not Associated with Increased Risk of Brain Radionecrosis. Int J Radiat Biol Phys 108(3):e2, 2020. PMID: None.
10. Palmer J, Klamer B, Ballman K, Brown P, Cerhan J, Anderson SK, Whitton A, Greenspoon J, Chung C, Burri S, Parney I, Stieber V, Pollock B, Laack N, Ashman J, Bahary JP, Barker F, Galanis E, Asher A, Roberge D. Modelling Neurocognitive Change Using Brain Substructure Dosimetry In Adults With Primary Brain Tumors. Neuro Oncol 22(2):40-41, 2020. PMID: None.
11. Anakwenze CP, McGovern S, Taku N, Liao K, Boyce-Fappiano DR, Kamiya-Matsuoka C, Ghia A, Chung C, Trifiletti D, Ferguson SD, Li J, Yeboa DN. Association between Facility Volume and Overall Survival for Patients with Grade II Meningioma after Gross Total Resection. Int. J. Radiat. Oncol. Biol. Phys 108(2):E7-E7, 2020. PMID: None.
12. Al Feghali K, Buszek S, Elhalawani H, Chevli N, Allen PK, Chung C. Real-world evaluation of the impact of radiotherapy and chemotherapy in elderly patients with glioblastoma based on age and performance status. Neurooncol Pract, 2020. PMID: None.
13. Hormuth DA, Al Feghali K, Elliot AM, Chung C, Yankeelov T. A biologically-motivated mathematical model for forecasting chemoradiationresponse in high grade gliomas: Initial results. Cancer Res 80(16):5847, 2020. PMID: None.
14. Mitchell D, Buszek SM, Tran B, Liu H, Suki D, Ferguson S, Chung AC. Comparison of Radiomic Feature Variability between Different MR Pulse Sequences in Brain Metastases. AAPM, 2020. PMID: None.
15. Slagowski JM, Ding Y, Aima M, Wen Z, Fuller CD, Chung C, Debnam JM, Hwang KP, Kadbi M, Szklaruk J, Wang J. A modular phantom and software to characterize 3D geometric distortion in MRI. Phys Med Biol. e-Pub 2020. PMID: 32531763.
16. Li J, Wang Y, Tang C, Welsh JW, Guha-Thakurta N, Carter BW, Wefel JS, Ghia AJ, Yeboa D, McAleer MF, Chung C, Woodhouse KD, Elamin Y, Le XN, Cascone T, Negrao MV, Skoulidis F, Ferrarotto R, Heymach J, Altan M. Concurrent nivolumab and ipilimumab with brain stereotactic radiosurgery for brain metastases from non-small cell lung cancer: A phase I trial. J. Clin. Oncol 38(15), 2020. PMID: None.
17. McGovern S, Luo D, Johnson M, Nguyen K, Li J, McAleer M, Yeboa D, Grosshans D, Ghia A, Chung C, Thall P, Sulman E, Brown P, Mahajan A. Prospective Trial of Conventionally Fractionated Dose Constraints for Re-Irradiation of Primary Brain Tumors. Neurooncol 21:214-214, 2019. PMID: None.
18. Al Feghali K, Randall J, Wefel J, Guha-Thakurta N, Grosshans D, Dibaj S, McAvoy S, Li J, McGovern S, McAleer M, Ghia A, Paulino A, Sulman E, Penas-Prado M, Wang JH, DeGroot J, Heimberger A, Armstrong T, Gilbert M, Mahajan A, Brown P, C <. Prospective Phase II Randomized Trial Comparing Proton Therapy vs. Photom IMRT for GBM: Secondary Analysis Comparison of Progression Free Survival Between RANO Vs. Clinical and Radiological Assessment. Neurooncol 21:161-162, 2019. PMID: None.
19. Randall K, Al Feghali K, Wefel J, Grosshans D, Dibaj S, Milton D, McAvoy S, Li J, McGovern S, McAleer M, Ghia A, Paulino A, Sulman E, Penas-Prado M, Wang JH, DeGroot J, Heimberger A, Armstrong T, Gilbert M, Mahajan A, Brown P, Chung C. Prospective Phase II Randomized Trial Comparing Proton Therapy vs. Photon IMRT for Newly Diagnosed GBM: Secondary Analysis Comparison of Gender and Neutrophil-Lymphocyte Ration (NLR) in GBM Outcomes. Neurooncol 21:213-213, 2019. PMID: None.
20. Szabolcs D, Mesri HY, Bodiut VA, Nagtegaal HJ, Elhalwani H, de Luca A, Philippens ME, Viergever MA, Mohamed AS, Ding Y, Chung C, Fuller CD, Verhoeff JC, Leemans A. Dose-dependent degeneration of non-cancerous brain tissue in post-radiotherapy patients: A diffusion tensor imaging study. None, 2019. PMID: None.
21. Thrower S, Luo D, Brock K, Chung C. MRI Slice Thickness Impacts the Detection and Treatment of Brain Metastases. Medical Physics 46(6):E309-E309, 2019. PMID: None.
22. Vedam S, Yang J, Cd F, Chung C, Balter P, Lee B, Castillo P, Hughes N, Ungchusri G, McAleer M, Koong A, Herman J, Gillin M, Martel M, Wang J. First MR-Guided Online Adaptive Patient Treatment in North America On An In-Room High Field (1.5 T) MRI Linac. Medical Physics 46(6):E229-E229, 2019. PMID: None.
23. Yang J, Vedam S, Wang J, Fuller CD, Choi S, Chung C, McAleer M, Lee B, Hughes N, Ungchusri G, Gillin M, Martel M, Balter P. Clinical Experience of Patient-Specific QA for Online Adaptive Radiotherapy Using Elekta Unity MR-Linac. Medical Physics 46(6):E204-E204, 2019. PMID: None.
24. Goldman J, Buszek S, Starr B, Al Feghali K, Chevli N, Allen P, Chung C. Comparison of Outcomes and Optimal Treatments Between Unifocal and Multifocal Glioblastoma Using the National Cancer Database. International Journal of Radiation Oncology Biology Physics 103(5):E7-E7, 2019. PMID: None.
25. Elhalawani H, Li TF, Al Feghali K, Radwan S, Ding Y, Jin Y, Mohamed A, Fuller CD, Zhu HT, Chung C. Early Evaluation of Radiation-induced White Matter Injury Following High Dose Fractionated Radiation Therapy in Patients with Glioblastoma Using Serial Diffusion Tensor Imaging (DTI). International Journal of Radiation Oncology Biology Physics 103(5):E28-E28, 2019. PMID: None.
26. Zaid M, Bajaj N, Mathew R, Chung C, Wilke C, Fuller CD, Andersen MR, Gunn B, Morrison W, Garden AS, Frank SJ, Rosenthal D, Adegbenga OO, Chambers MS, Koay E. A Prospective Trial Evaluating Patient Reported Outcomes of Customized Oral Stents for Head and Neck (HN) Radiotherapy (RT) Using 3D Printing and Traditional Methods. Int. J. Radiat. Oncol. Biol. Phys 103(5):E35-E36, 2019. PMID: None.
27. Slagowski JM, Ding Y, Wen Z, Fuller CD, Chung C, Kadbi M, Ibbot GS, Wang J. Quantification of Geometric Distortion in Magnetic Resonance Imaging for Radiation Therapy Treatment Planning. International Journal of Radiation Oncology Biology Physics 102(3):E547-E547, 2018. PMID: None.
28. Al Feghali K, Elhalawani H, Buszek SM, Chevli NC, Allen PK, Chung C. Interplay of Age and Performance Status on Patterns of Care and Outcomes in Elderly Patients with Glioblastoma: A National Cancer Database Analysis. International Journal of Radiation Oncology Biology Physics 102(3):E201-E202, 2018. PMID: None.
29. Buszek SM, Al Feghali K, Elhalawani H, Chevli N, Allen P, Chung C. Predictors for and Clinical Impact of Time between Surgical Resection and Radiotherapy in Glioblastoma: Analysis of the National Cancer Database (2018). International Journal of Radiation Oncology Biology Physics 102(3):E260-E261, 2018. PMID: None.
30. Elhalawani H, Lin T, Al Feghali K, Radwan S, Chevli N, Mohamed A, Fuller CD, Chung C. Investigating Semi-Quantitative in-vivo Spatial and Dosimetric Analytical Algorithms to Report GBM Patterns of Failures following chemoradiation in the IMRT era. None 102(3):E241-E241, 2018. PMID: None.
31. Elhalawani H, Li T, Radwan S, Al Feghali K, Ding Y, Mohamed A, Fuller CD, Zhu H, Chung C. Radiation-induced White Matter Injury Following Radiation Therapy in Glioblastoma patients. International Journal of Radiation Oncology Biology Physics 102(3):E216-E216, 2018. PMID: None.
32. Al Feghali K, Buszek SM, Elhalawani H, Chevli N, Allen PK, Chung C. Real-Word Evaluation of the Impact of Radiotherapy and Chemotherapy in Elderly Patients with Glioblastoma based on Age and Performance Status: A National Cancer Database Analysis. Neuro-Oncology 20:117-117, 2018. PMID: None.
33. Netherton T, Cardenas C, Klopp A, Baker P, Chung C, Peterson C, Howell R, Court L. Automated Detection of Vertebral Body Metastases for Fully-Automated Palliative Radiotherapy Using Transfer Learning. Medical Physics 45(6):E449-E449, 2018. PMID: None.
34. Winter J, Moraes F, Chung C, Coolens C. Investigation of Dose-Correlated MR Biomarker Changes in Brain Metastases Post-SRS. Medical Physics 45(6):E580-E580, 2018. PMID: None.
35. Anderson B, Elsohari B, Cardenas C, Mohamed A, Yang P, Fuller CD, Chung C, Brock K. Deep Learning for Head and Neck Segmentation in MR: A Tool for the MR-Guided Radiotherapy. Medical Physics 45(6):E634-E364, 2018. PMID: None.
36. He R, Ding Y, Mohamed A, Elhalawani H, Ger R, Elgohari B, Wang J, Brock K, Chung C, Hutcheson K, Frank S, Lai S, Fuller CD. Improve IVIM & DCE Map Using Convex Optimization with Higher-Order Total-Variation Regularizations. Medical Physics 45(6):E215-E215, 2018. PMID: None.
37. Chevli N, Elhalwani H, Mohamed A, Mahajan A, Weinberg J, Fuller CD, Chung C. Prognostic Impact of Timing Between Surgery and Radiotherapy (RT) in Patients with Glioblastoma (GBM). Neurooncol 19:219-219, 2017. PMID: None.
38. Chung C, Brown PD, McAvoy S, Grosshans DR, Dibaj S, Guha-Thakurta N, Li J, McGovern SL, McAleer MF, Ghia A, Paulino A, Sulman E, Penas-Prado M, Wang J, de Groot J, Heimberger A, Armstrong TS, Gilbert MR, Mahajan A, Wefel J. A Prospective Phase II Randomized Trial to Compare Intensity Modulated Proton Radiotherapy (IMPT) VS. Intensity Modulated Radiotherapy (IMRT) for Newly Diagnosed Glioblastoma (GBM). Neurooncol 19:16-16, 2017. PMID: None.
39. Raziee H, Moraes F, Cho YB, Maganti M, Shultz D, Millsr BA, Laperriere N, Chung C, Berlin A. Assessment of Dosimetric Predictors and Impact of Whole-Brain Radiation Therapy on the Incidence of Radionecrosis after Stereotactic Radiosurgery for Brain Metastasis. Int. J. Radiat. Oncol. Biol. Phys 99(2):E103-E103, 2017. PMID: None.
40. Muhlestein W, Chambless LB, Pajewski NM, Braunstein SE, Hepel J, Chung C, Contessa JN, Chao ST, Fiveash JB, Attia A, Chan MD, Ayala-Peacock D. Using a Novel Machine Learning Technique to Predict Radiation Oncology Outcomes. Int. J. Radiat. Oncol. Biol. Phys 99(2):E422-E423, 2017. PMID: None.
41. Muhlestein W, Farris M, McTyre E, Pajewski NM, Attia A, Chambless LB, Braunstein SE, Hepel JT, Chung C, Contessa JN, Chao ST, Fiveash JB, Chan MD, Ayala-Peacock DN. Using a Novel Machine Learning Technique to Predict Brain Metastasis Velocity Following Stereotactic Radiosurgery for Brain Metastases. Int. J. Radiat. Oncol. Biol. Phys 99(2):E96, 2017. PMID: None.
42. Ger R, Mohamed A, Awan M, Ding Y, Li K, Fave X, Beers A, Driscoll B, Elhalwani H, Hormuth D, van Houdt P, He R, Zhou S, Mathieu K, Li H, Coolens C, Chung C, Bankson J, Huang W, Wang J, Sandulache V, Lai S, Howell R, Stafford R, Yankeelov T, van der Heide U, Frank S, Barboriak D, Hazle J, Court L, Kalpathy-Cramer J, Fuller C. Comparison of Parameter Calculation Algorithms for DCE-MRI: Results from a Multi-Institutional Study. Medical Physics 44(6):3097-3097, 2017. PMID: None.
43. Johnson JM, Jen ML, Shin DD, Hou P, Chung C, Schomer DF, Liu HL. Effect of Lesion-related Signal Variation in Proton Density Reference Image on Blood Flow Quantification with Arterial Spin Labeling MRI for Differentiating Pseudoprogression from True Progression in Gliomas. None. e-Pub 2017. PMID: None.
44. Hahn E, Velazquez-Martin JP, Somani S, Payne D, Waldron J, Krema H, Simpson R, Laperriere N, Chung C. Hypofractionated Palliative Radiation Therapy for Choroidal Metastases: Clinical Outcomes and Predictors of Overall Survival. International Journal of Radiation Oncology Biology Physics 96(2S):E510, 2016. PMID: None.
45. Rodin D, Banlhashemi B, Wang L, Lau A, Harris S, Levin W, Dinniwell R, Millar BA, Chung C, Laperriere N, Bezjak A, Wong RKS. The Brain Metastases Symptom Checklist as a Novel Tool for Symptom Measurement in Patients with Brain Metastases Undergoing Whole-Brain Radiotherapy. Curr Oncol 23(3):239, 2016. PMID: None.
46. Turner S, Alizadeh M, Leigh N, Shepherd FA, Zadeh G, Laperriere N, Millar BA, Bernstein M, Bedard P, Chung C. Effect of molecular profile in non-small cell lung carcinoma on the development of brain metastases. J. Clin. Oncol 34(15):e20620-e20640, 2016. PMID: None.
47. Doherty M, Korpanty G, Alizadeh M, Jao K, Labbe C, Mascaux C, Martin P, Kamel-Reid S, Pintilie M, Liu G, Bradbury PA, Feld R, Leighl NB, Chung C, Shepherd FA. Effect of brain metastases on survival and systemic treatment of EGFR/ALK-driven non-small cell lung cancer (NSCLC). J. Clin. Oncol 34(15):e20527-e20527, 2016. PMID: None.
48. Richard N, Bernstein LJ, Mason WP, Laperriere N, Chung C, Millar BA, Maurice C, Edelstein K. Cognitive rehabilitation for brain tumor survivors: A pilot study. J. Clin. Oncol 34(3):140-140, 2016. PMID: None.
49. Coolens C, Driscoll B, Foltz W, Chung C. mpact of Arterial Input Function Selection and T10 Correction On DCE‐MRI Tumour Response Prediction Using Compared to Volumetric DCE CT. Medical Physics 42(6):3215-3215, 2015. PMID: None.
50. Ghobadi K, Aleman D, Li W, Chung C, Jaffray D. Continuous Dose Delivery wih Gamma Knife Perfexion. Medical Physics 42(6):3576, 2015. PMID: None.
51. Coolens C, Driscoll B, Foltz W, Chung C. Input function selection and T10 correction on DCE-MRI tumor response prediction using compared to volumetric DCE CT. Med Phys 42(6):3215, 2015. PMID: 26127196.
52. Khoja L, Kurtz G, Bernstein M, Joshua A, Hogg D, Zadeh G, Laperriere N, Mernard C, Miller BA, Kongkham P, Atenafu EG, Butler MC, Chung C. Brain radiosurgery and ipilimumab (Ipi) in melanoma brain metastases (MBM) patients: Does an enhanced immune response induce radionecrosis (RN)?. J. Clin. Oncol 33(15):e20019-e20019, 2015. PMID: None.
53. Tieu MT, Lovblom LE, McNamara M, Mason W, Laperriere N, Millar BA, Menard C, Kiehl TR, Perkins BA, Chung C. Impact of Glycemia on Survival in Glioblastoma Patients. J Neurooncol, 2015. PMID: None.
54. Brown PD, Asher AL, Ballman KV, Farace E, Cerhan JH, Anderson SK, Carrero XW, Barker FG, Deming RL, Burris S, Menard C, Chung C, Stieber VW, Pollock BE, Galanis E, Buckner JC, Jaeckle KA. NCCTG N0574 (Alliance): A Phase III Randomized Trial of Whole Brain Radiation Therapy (WBRT) in Addition to Radiosurgery (SRS) in Patients with 1 to 3 Brain Metastases. Journal of Clinical Oncology 33(15 (Supl)), 2015. PMID: None.
55. Richard NM, Bernstein LJ, Mason WP, Laperriere N, Chung C, Millar BA, Maurice C, Edelstien K. Rehabilitation of cognitive dysfunction in brain tumor patients. J Clin Oncol 33(15), 2015. PMID: None.
56. Lymberiou T, Galuszka S, Lee G, Xu W, Su S, Fyles A, Purdie T, Catton P, Chung C, Dinniwell R, Han K, Koch A Levin W, Manchul L, Sappiatzer J, Mackenzie P, Liu FF. Predictors of breast radiotherapy plan modifications: Quality assurance rounds in a large cancer centre. Asia-Pacific Journal of Clinical Oncology 10:170, 2014. PMID: None.
57. Mason M, McNamara M, Tieu M, Lwin Z, Millar BA, Menard C, Laperriere N, Milosevic M, Mason W, Chung C. Prognostic value of early changes in neutrophil and lymphocyte measures during chemoradiotherapy for glioblastoma. Neuro-Oncology 16:v191, 2014. PMID: None.
58. Mason MT, McNamara MG, Tieu MT, Lwin Z, Millar BA, Menard C, Laperriere N, Milosevic M, Mason WP, Chung C. Reduction in neutrophil-lymphocyte ratio during initial concurrent chemoradiotherapy is prognostic for survival of glioblastoma patients. Neuro-Oncology 16:ii23-ii24, 2014. PMID: None.
59. Edelstein K, Laperriere N, Bernstein L, Simpson R, Chung C, Millar MA, Mason WP. Neurocognitive functions in adults treated with radiation for primary brain tumors: A longitudinal study. J Clin Oncol 32(5s), 2014. PMID: None.
60. Adilman R, Rajmohan Y, Trinkaus M, Chung C, Naseem M, Hammad N, Leonard R, Urgoiti GR, Brooks E, Poonja Z, Simmons CE. Social media use amongst oncologists: Results of a national physician survey. Journal of Clinical Oncology 32(15 (Supl 1)), 2014. PMID: None.
61. Bender J, Singh Ubhi K, Alkazaz N, Catton P, Dinniwell R, Fyles A, Manchul L, Levin W, Liu FF, McCready D, Chung C. Low-risk Breast Cancer Patients’ Perceptions of Alternative Models of Survivorship Care. Radiotherap Oncol, 2013. PMID: None.
62. Jalali S, Chung C, Burrell K, Foltz W, Zadeh G. Non-invasive MRI biomarkers of response to anti-angiogenic therapy in glioblastoma multiforme. Neuro-Oncology 15(iii4), 2013. PMID: None.
63. McNamara MG, Lwin Z, Jiang H, Chung C, Millar BA, Sahgal A, Laperriere N, Mason WP. Does time to first progression (TTP) impact post-progression survival in glioblastoma (GBM) in the temozolomide (TMZ) treatment era?. Neuro-Oncology 15(iii120), 2013. PMID: None.
64. Vera-Bolanos E, Acquaye AA, Brown PD, Chung C, Gilbert MR, Vardy J, Armstrong TS. Structure and reliability of the dexamethasone symptom questionnaire-chronic in primary or metastatic brain tumor patients. Neuro-Oncology 15(iii233), 2013. PMID: None.
65. Menjak IB, Maki E, Berman HK, Chung C, McCready DR, Sridhar SS. Impact of endocrine therapy in early-stage breast cancer on time to locoregional recurrence. Journal of Clinical Oncology 31(26 Supl), 2013. PMID: None.
66. Lee SL, Foltz W, Driscoll B, Fatemi A, Ménard C, Coolens C, Chung C. Comparison of Arterial Input Functions by Magnitude and Phase Signal Measurement in Dynamic Contrast Enhancement MRI using a Dynamic Flow Phantom. Magn Reson Med, 2012. PMID: None.
67. Jalali S, Foltz W, Burrell K, Chung C, Zadeh G. Identification of MRI biomarkers and histopathological alterations in response to combination therapy with antiangiogenic agents and radiation in a murine model of glioma tumor, Part B, Skull Base. Journal of Neurological Surgery, 2012. PMID: None.
68. Ruschin M, De Jean P, Ansell S, Bootsma G, Chung C, Ménard C, Cho YB, Jaffray D. Initial performance characterization and clinical implementation of a novel image-guided system for Perfexion. J Neurosurg, 2012. PMID: None.
69. Chung C, Millar BA, Menard C, Zadeh G, Bernstein M, Laperriere N. Radiosurgery for Brainstem Metastases. J Neurosurg, 2012. PMID: None.
70. Jalali S, Foltz W, Burrell K, Lee JI, Agnihorti S, Menard C, Chung C, Zadeh G. Identification of MRI biomarkers and histopathological alterations in response to combinatorial therapy with sunitinib and radiation in a murine model of glioma. Neuro-Oncology 13:iii6-iii7, 2011. PMID: None.
71. Muneer A, Showkatian E, Sad MB, Hong L, Aminu M, Salehjahromi M, Sujit SJ, Waqas M, Li W, Vokes NI, Wu CC, Carter BW, Chang JY, Le X, Wistuba II, Chung C, Jaffray D, Gibbons DL, Vaporciyan A, Lee J, Heymach JV, Zhang J, Wu J. Predicting PD-L1 Expression from CT Scans Using Deep Learning to Guide Immunotherapy in Metastatic Non-Small-Cell Lung Cancer. None. PMID: None.
72. Buszek SM, Al Feghali K, Elhalawani H, Chevli N, Allen P, Chung C. Clinical Impact of Time Interval between Gross Total and Subtotal Resection of Glioblastoma and Radiotherapy using a Large National Database (2018). None. PMID: None.

Book Chapters

1. Buszek, SM, Chung, C. Radiation Therapy for Leptomeningeal Disease, 125-141, 2022.
2. Buszek SM, Chung C. Radiation Therapy of Leptomeningeal Disease. In: Radiopharmaceuticals in the Management of Leptomeningeal Metastasis. None. Springer, 125-141, 2022.
3. Chung, Caroline. The Cultures of Japanese Internment: A Short History of “Funny” Turns. In: Asian American Literature in Transition, 1930–1965. None. None, 68-86, 2021.
4. Al Feghali K, Chung C, Wefel JS, Bradshaw ME. Neurocognitive Toxicity from Radiation Therapy for Brain Metastases. In: Central Nervous System Metastases. None. Springer, 315-328, 2020.
5. Al Feghali K, Bradshaw ME, Chung C, Wefel JS. Neurocognitive Effects of Brain Metastases and Their Treatment. In: Central Nervous System Metastases, Diagnosis and Treatment. None. None, 407-425, 2020.
6. Buszek SM, Chung C. Radiotherapy in Leptomeningeal Disease: A Systematic Review of Randomized and Non-Randomized Trials. In: Front Oncol. None. None, 1224, 2019.
7. Al Feghali KA, Chung C, Wefel JS, Bradshaw ME. None. In: Neurocognitive Toxicity from Radiation Therapy for Brain Metastases. None. Springer, 2019.
8. Chung C, Kaufmann TJ. Brain Radionecrosis. In: In: Chang E., Brown P., Lo S., Sahgal A., Suh J. (eds) Adult CNS Radiation Oncology. None. Springer, Cham, 2018.
9. Shanker MD, Kaufmann TJ, C <. None. In: Brain Radionecrosis. In: Adult CNS Radiation Oncology: Principles and Practice. None. None, 2018.
10. Chung C, Do-Hyun, Stupp R. Central Nervous System. In: Manual of Clinical Oncology: Central Nervous System and Ocular Cancers. None. Wiley Online Library, 2017.
11. Chung C, Nam D, Stupp R. Central Nervous System. In: In book: UICC Manual of Clinical Oncology. None. Wiley Online Library, 2015.
12. Mawrin C, Chung C, Preusser M. Biology and clinical management challenges in meningioma. In: In: Am Soc Clin Oncol Educ Book. 35. None, 106-15, 2015.
13. Chung C, Nam D, Stupp R. CNS Tumors. In: Union for International Cancer Control (UICC) Manual of Clinical Oncology. None. None, 2014.
14. Chung C. Imaging biomarkers in preclinical studies on brain tumours'. In: Biomarkers in Disease: Methods, Discovers and Applications -- Biomarkers in Cancer. None. Springer, 2014.
15. Chung C, Chang E. Primary Tumors of the Central Nervous System. In: Radiation Oncology in Palliative Cancer Care. 1. John Wiley & Sons, Ltd, 2013.
16. Chung C, Laperriere N. Management of Intracranial Metastases. In: Principles and Practice of Palliative Care and Supportive Oncology. 4. Philadelphia: Lippincott Williams & Wilkins, 2012.
17. Chung C, Brade A. Radiosensitizers and Anti-angiogenic agents for brain metastases. In: Bone and Brain Metastases: Advances in research and treatment. None. New York: Nova Science Publishers, Inc, 2010.

Books (edited and written)

1. Casola L, Rapporteur, Mathematical Sciences BO, Analytics, Science C, Board T, Atmospheric Sciences BO, Climate, Life Sciences BO, Engineering DO, Sciences P, Earth DO, Studies L, of Engineering NA, of Sciences NA, Engineering, Medicine A. Opportunities and Challenges for Digital Twins in Biomedical Research: Proceedings of a Workshop—in Brief. Ed(s) None. National Academies Press, 2023.

Letters to the Editor

1. Pollard C, Li J, Chung C, DeMonte F, Phan J. In Reply to Tuleasca et al. Journal of Neurosurgery.